[S02DA03, antipyrine, The metabolism of Dacomitinib can be decreased when combined with Antipyrine.]
[J01EC02, sulfadiazine, The metabolism of Dacomitinib can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Dacomitinib can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The metabolism of Dacomitinib can be decreased when combined with Sulfamethoxazole.]
[J01EC03, sulfamoxole, The metabolism of Dacomitinib can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Dacomitinib can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Dacomitinib can be increased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Dacomitinib can be decreased when combined with Sulfisoxazole.]
[A10BB04, glibornuride, The metabolism of Dacomitinib can be decreased when combined with Glibornuride.]
[L02BA01, tamoxifen, The serum concentration of Dacomitinib can be increased when it is combined with Tamoxifen.]
[L01CB02, teniposide, The metabolism of Dacomitinib can be decreased when combined with Teniposide.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Dacomitinib.]
[G03BA03, testosterone, The metabolism of Dacomitinib can be increased when combined with Testosterone.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Dacomitinib.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Tetracaine.]
[S03AA02, tetracycline, The metabolism of Dacomitinib can be decreased when combined with Tetracycline.]
[A04AD10, dronabinol, The metabolism of Dacomitinib can be decreased when combined with Dronabinol.]
[L04AX02, thalidomide, The metabolism of Dacomitinib can be decreased when combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Dacomitinib.]
[A11DA01, thiamine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Thiamine.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Dacomitinib.]
[N05AC02, thioridazine, The metabolism of Dacomitinib can be decreased when combined with Thioridazine.]
[C01BB04, aprindine, The metabolism of Dacomitinib can be decreased when combined with Aprindine.]
[V04CJ01, thyrotropin, The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Dacomitinib.]
[V04CJ02, thyrotropin-releasing hormone, The therapeutic efficacy of Protirelin can be decreased when used in combination with Dacomitinib.]
[B01AC05, ticlopidine, The metabolism of Dacomitinib can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Dacomitinib.]
[A10BB05, tolazamide, The metabolism of Dacomitinib can be decreased when combined with Tolazamide.]
[V04CA01, tolbutamide, The metabolism of Dacomitinib can be decreased when combined with Tolbutamide.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Dacomitinib.]
[N06AF04, tranylcypromine, The metabolism of Dacomitinib can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The serum concentration of Dacomitinib can be decreased when it is combined with Trazodone.]
[L01XF01, tretinoin, The metabolism of Dacomitinib can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The metabolism of Dacomitinib can be increased when combined with Triamcinolone.]
[R03BA07, mometasone, The metabolism of Dacomitinib can be increased when combined with Mometasone.]
[N03AC02, trimethadione, The metabolism of Dacomitinib can be decreased when combined with Trimethadione.]
[J01EA01, trimethoprim, The metabolism of Dacomitinib can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Dacomitinib.]
[R06AC04, tripelennamine, The metabolism of Dacomitinib can be decreased when combined with Tripelennamine.]
[J01FA08, troleandomycin, The metabolism of Dacomitinib can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Dacomitinib can be decreased when combined with Vilazodone.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Tubocurarine.]
[R03DX07, roflumilast, The metabolism of Dacomitinib can be decreased when combined with Roflumilast.]
[L01EX04, vandetanib, The serum concentration of Dacomitinib can be increased when it is combined with Vandetanib.]
[L02BX03, abiraterone, The metabolism of Dacomitinib can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The serum concentration of Dacomitinib can be increased when it is combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Dacomitinib can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Dacomitinib can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Dacomitinib can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, The metabolism of Ezogabine can be decreased when combined with Dacomitinib.]
[B01AF01, rivaroxaban, Dacomitinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, The serum concentration of Indacaterol can be increased when it is combined with Dacomitinib.]
[B01AC24, ticagrelor, The serum concentration of Dacomitinib can be increased when it is combined with Ticagrelor.]
[C08DA01, verapamil, The serum concentration of Dacomitinib can be increased when it is combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Dacomitinib can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be increased when it is combined with Dacomitinib.]
[L01CA02, vincristine, The excretion of Vincristine can be decreased when combined with Dacomitinib.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Dacomitinib.]
[A11HA03, vitamin E, The metabolism of Dacomitinib can be increased when combined with Vitamin E.]
[B01AA03, warfarin, The metabolism of Dacomitinib can be increased when combined with Warfarin.]
[J05AF01, zidovudine, Dacomitinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N05AF05, zuclopenthixol, The metabolism of Dacomitinib can be decreased when combined with Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Dacomitinib can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Dacomitinib can be increased when it is combined with Vemurafenib.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be increased when it is combined with Dacomitinib.]
[L01ED01, crizotinib, The metabolism of Dacomitinib can be decreased when combined with Crizotinib.]
[R03DC01, zafirlukast, The metabolism of Dacomitinib can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Rabeprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AE04, ziprasidone, The metabolism of Dacomitinib can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Dacomitinib can be decreased when combined with Drospirenone.]
[N02BA01, aspirin, The metabolism of Dacomitinib can be decreased when combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Dacomitinib.]
[G04BD07, tolterodine, The metabolism of Dacomitinib can be decreased when combined with Tolterodine.]
[C07AB03, atenolol, The metabolism of Dacomitinib can be decreased when combined with Atenolol.]
[J02AC03, voriconazole, The serum concentration of Dacomitinib can be increased when it is combined with Voriconazole.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L01EK01, axitinib, The serum concentration of Axitinib can be increased when it is combined with Dacomitinib.]
[R07AX02, ivacaftor, The serum concentration of Dacomitinib can be increased when it is combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Dacomitinib can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Dacomitinib.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Dacomitinib.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Dacomitinib.]
[A08AA11, lorcaserin, The metabolism of Dacomitinib can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Dacomitinib can be increased when it is combined with Mirabegron.]
[L01XG02, carfilzomib, The serum concentration of Dacomitinib can be increased when it is combined with Carfilzomib.]
[V03AX03, cobicistat, The metabolism of Dacomitinib can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Dacomitinib can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Dacomitinib can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Dacomitinib.]
[L04AA31, teriflunomide, Teriflunomide may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L01EX05, regorafenib, The serum concentration of Dacomitinib can be increased when it is combined with Regorafenib.]
[N05CA04, barbital, The metabolism of Dacomitinib can be increased when combined with Barbital.]
[J05AE04, nelfinavir, The metabolism of Dacomitinib can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Dacomitinib.]
[N06DA02, donepezil, The metabolism of Dacomitinib can be decreased when combined with Donepezil.]
[N03AX22, perampanel, The metabolism of Dacomitinib can be increased when combined with Perampanel.]
[G04BD10, darifenacin, The metabolism of Dacomitinib can be decreased when combined with Darifenacin.]
[L01EX07, cabozantinib, The metabolism of Dacomitinib can be decreased when combined with Cabozantinib.]
[H01CB05, pasireotide, The metabolism of Dacomitinib can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The serum concentration of Dacomitinib can be increased when it is combined with Sildenafil.]
[L01EA05, ponatinib, The serum concentration of Dacomitinib can be increased when it is combined with Ponatinib.]
[B01AF02, apixaban, Dacomitinib may decrease the excretion rate of Apixaban which could result in a higher serum level.]
[C10AX12, lomitapide, The serum concentration of Dacomitinib can be increased when it is combined with Lomitapide.]
[A10BH04, alogliptin, The metabolism of Dacomitinib can be decreased when combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Dacomitinib can be increased when combined with Glycerol phenylbutyrate.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Dacomitinib.]
[G03XC05, ospemifene, The metabolism of Dacomitinib can be decreased when combined with Ospemifene.]
[A10BK02, canagliflozin, The serum concentration of Dacomitinib can be increased when it is combined with Canagliflozin.]
[M04AB03, benzbromarone, The metabolism of Dacomitinib can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The metabolism of Dacomitinib can be decreased when combined with Tegaserod.]
[H03AA04, tiratricol, The therapeutic efficacy of Tiratricol can be decreased when used in combination with Dacomitinib.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Dacomitinib can be decreased when combined with Celecoxib.]
[L04AA18, everolimus, The serum concentration of Everolimus can be increased when it is combined with Dacomitinib.]
[N04AC01, benztropine, The metabolism of Dacomitinib can be decreased when combined with Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Dacomitinib can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Benzyl alcohol.]
[H05AA03, parathyroid hormone, The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Dacomitinib.]
[L01EB03, afatinib, The serum concentration of Afatinib can be increased when it is combined with Dacomitinib.]
[N06AX28, levomilnacipran, The metabolism of Dacomitinib can be decreased when combined with Levomilnacipran.]
[J05AJ03, dolutegravir, Dacomitinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.]
[C08EA02, bepridil, The metabolism of Dacomitinib can be decreased when combined with Bepridil.]
[C02KX05, riociguat, Dacomitinib may decrease the excretion rate of Riociguat which could result in a higher serum level.]
[G03XC02, bazedoxifene, The metabolism of Bazedoxifene can be decreased when combined with Dacomitinib.]
[L01EL01, ibrutinib, The metabolism of Dacomitinib can be decreased when combined with Ibrutinib.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Dacomitinib.]
[N03AF04, eslicarbazepine, The metabolism of Dacomitinib can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The serum concentration of Dacomitinib can be increased when it is combined with Simeprevir.]
[J05AP08, sofosbuvir, Dacomitinib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The metabolism of Dacomitinib can be decreased when combined with Dapagliflozin.]
[C07AB04, acebutolol, The metabolism of Dacomitinib can be decreased when combined with Acebutolol.]
[N05CH03, tasimelteon, The metabolism of Dacomitinib can be decreased when combined with Tasimelteon.]
[A16AA07, metreleptin, The metabolism of Dacomitinib can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Dacomitinib can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Dacomitinib can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Dacomitinib can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The metabolism of Dacomitinib can be decreased when combined with Betaxolol.]
[L04AC11, siltuximab, The metabolism of Dacomitinib can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The serum concentration of Ceritinib can be increased when it is combined with Dacomitinib.]
[B01AC26, vorapaxar, The serum concentration of Dacomitinib can be increased when it is combined with Vorapaxar.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Dacomitinib.]
[L01XH04, belinostat, The metabolism of Belinostat can be decreased when combined with Dacomitinib.]
[L01EM01, idelalisib, The metabolism of Dacomitinib can be decreased when combined with Idelalisib.]
[N07XX08, tafamidis, The serum concentration of Dacomitinib can be increased when it is combined with Tafamidis.]
[R03AC19, olodaterol, The metabolism of Dacomitinib can be decreased when combined with Olodaterol.]
[N05CM19, suvorexant, The serum concentration of Dacomitinib can be increased when it is combined with Suvorexant.]
[A16AX10, eliglustat, The metabolism of Dacomitinib can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Dacomitinib can be increased when combined with Oritavancin.]
[A06AH03, naloxegol, The serum concentration of Naloxegol can be increased when it is combined with Dacomitinib.]
[N04AA02, biperiden, The metabolism of Dacomitinib can be decreased when combined with Biperiden.]
[L04AX05, pirfenidone, The metabolism of Dacomitinib can be decreased when combined with Pirfenidone.]
[L01EX09, nintedanib, The metabolism of Dacomitinib can be decreased when combined with Nintedanib.]
[J05AP09, dasabuvir, The metabolism of Dacomitinib can be decreased when combined with Dasabuvir.]
[L01XK01, olaparib, The metabolism of Dacomitinib can be decreased when combined with Olaparib.]
[B01AA01, dicumarol, The metabolism of Dacomitinib can be decreased when combined with Dicoumarol.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Dacomitinib.]
[N06AX11, mirtazapine, The metabolism of Dacomitinib can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Dacomitinib can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The serum concentration of Dacomitinib can be increased when it is combined with Palbociclib.]
[L01EX08, lenvatinib, Dacomitinib may decrease the excretion rate of Lenvatinib which could result in a higher serum level.]
[L01XH03, panobinostat, The metabolism of Dacomitinib can be decreased when combined with Panobinostat.]
[J05AP07, daclatasvir, The serum concentration of Dacomitinib can be increased when it is combined with Daclatasvir.]
[N02BE01, acetaminophen, The metabolism of Dacomitinib can be increased when combined with Acetaminophen.]
[J05AP06, asunaprevir, The metabolism of Dacomitinib can be decreased when combined with Asunaprevir.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Dacomitinib.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Dacomitinib.]
[A04AD14, rolapitant, The metabolism of Dacomitinib can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, The serum concentration of Dacomitinib can be increased when it is combined with Flibanserin.]
[S01EC01, acetazolamide, The metabolism of Dacomitinib can be decreased when combined with Acetazolamide.]
[A02BC03, lansoprazole, Lansoprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Dacomitinib.]
[J02AC05, isavuconazole, The serum concentration of Dacomitinib can be increased when it is combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be increased when it is combined with Dacomitinib.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Dacomitinib.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Dacomitinib.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Dacomitinib.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Dacomitinib.]
[B01AC27, selexipag, The serum concentration of Selexipag can be increased when it is combined with Dacomitinib.]
[A10BB31, acetohexamide, The metabolism of Dacomitinib can be decreased when combined with Acetohexamide.]
[M04AB05, lesinurad, The metabolism of Dacomitinib can be increased when combined with Lesinurad.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[N05CA05, aprobarbital, The metabolism of Dacomitinib can be increased when combined with Aprobarbital.]
[N03AX23, brivaracetam, The metabolism of Dacomitinib can be decreased when combined with Brivaracetam.]
[L01XX52, venetoclax, The serum concentration of Dacomitinib can be increased when it is combined with Venetoclax.]
[N05AX17, pimavanserin, The metabolism of Dacomitinib can be decreased when combined with Pimavanserin.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Bupivacaine.]
[C07AA19, bupranolol, The metabolism of Dacomitinib can be decreased when combined with Bupranolol.]
[N07BC01, buprenorphine, The metabolism of Dacomitinib can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, The metabolism of Dacomitinib can be decreased when combined with Buspirone.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Dacomitinib.]
[L01XX27, arsenic trioxide, The serum concentration of Dacomitinib can be increased when it is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Dacomitinib can be decreased when combined with Artemether.]
[M02AA03, clofezone, Rabeprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01GX07, azelastine, The metabolism of Dacomitinib can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Dacomitinib can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Dacomitinib can be decreased when combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Dacomitinib can be decreased when combined with Ribociclib.]
[N07XX16, deutetrabenazine, The serum concentration of the active metabolites of Deutetrabenazine can be increased when Deutetrabenazine is used in combination with Dacomitinib.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Oxybuprocaine.]
[D05AX03, calcitriol, The metabolism of Dacomitinib can be increased when combined with Calcitriol.]
[J05AF06, abacavir, The metabolism of Abacavir can be decreased when combined with Dacomitinib.]
[J05AE09, tipranavir, The metabolism of Dacomitinib can be decreased when combined with Tipranavir.]
[H03BA03, benzylthiouracil, The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Dacomitinib.]
[N07XX13, valbenazine, The metabolism of Dacomitinib can be decreased when combined with Valbenazine.]
[L04AB02, infliximab, The metabolism of Dacomitinib can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Dacomitinib can be decreased when combined with Midostaurin.]
[H05AA04, abaloparatide, The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Dacomitinib.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Dacomitinib.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L04AC14, sarilumab, The metabolism of Dacomitinib can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Dacomitinib can be increased when combined with Delafloxacin.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Dacomitinib.]
[D01AC10, bifonazole, The metabolism of Dacomitinib can be decreased when combined with Bifonazole.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Acetylcholine.]
[L01BC06, capecitabine, The metabolism of Dacomitinib can be decreased when combined with Capecitabine.]
[L01XX59, enasidenib, The serum concentration of Dacomitinib can be increased when it is combined with Enasidenib.]
[L01EH02, neratinib, The serum concentration of Dacomitinib can be increased when it is combined with Neratinib.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Dacomitinib.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be increased when it is combined with Dacomitinib.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be increased when it is combined with Dacomitinib.]
[C07AB07, bisoprolol, The serum concentration of Bisoprolol can be increased when it is combined with Dacomitinib.]
[J05AG03, efavirenz, The metabolism of Dacomitinib can be decreased when combined with Efavirenz.]
[C07AA17, bopindolol, The metabolism of Dacomitinib can be decreased when combined with Bopindolol.]
[R03BA02, budesonide, The metabolism of Dacomitinib can be increased when combined with Budesonide.]
[L01EL02, acalabrutinib, The metabolism of Dacomitinib can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, The metabolism of Dacomitinib can be decreased when combined with Letermovir.]
[C01AA02, acetyldigoxins, Dacomitinib may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Capsaicin.]
[A10BK04, ertugliflozin, Dacomitinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.]
[L02BB05, apalutamide, The serum concentration of Dacomitinib can be decreased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Dacomitinib can be increased when combined with Carbamazepine.]
[H03BB01, carbimazole, The therapeutic efficacy of Carbimazole can be decreased when used in combination with Dacomitinib.]
[C07AG02, carvedilol, The serum concentration of Dacomitinib can be increased when it is combined with Carvedilol.]
[B02BX09, fostamatinib, The metabolism of Dacomitinib can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Dacomitinib can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The metabolism of Dacomitinib can be increased when combined with Avatrombopag.]
[L01EC03, encorafenib, The metabolism of Dacomitinib can be decreased when combined with Encorafenib.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Dacomitinib.]
[C07AB08, celiprolol, The metabolism of Dacomitinib can be decreased when combined with Celiprolol.]
[H01CC03, elagolix, The serum concentration of Dacomitinib can be increased when it is combined with Elagolix.]
[L01XX62, ivosidenib, The metabolism of Dacomitinib can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Dacomitinib can be decreased when combined with Tafenoquine.]
[A16AX14, migalastat, The metabolism of Migalastat can be decreased when combined with Dacomitinib.]
[N03AX17, stiripentol, The metabolism of Dacomitinib can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Dacomitinib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[J05AX24, tecovirimat, The metabolism of Dacomitinib can be increased when combined with Tecovirimat.]
[L01EM04, duvelisib, The metabolism of Dacomitinib can be decreased when combined with Duvelisib.]
[S01AA13, fusidic acid, The metabolism of Dacomitinib can be decreased when combined with Fusidic acid.]
[J01AA14, sarecycline, The serum concentration of Dacomitinib can be increased when it is combined with Sarecycline.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Dacomitinib.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Dacomitinib.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Chloroprocaine.]
[M01AC05, lornoxicam, The metabolism of Dacomitinib can be decreased when combined with Lornoxicam.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be increased when it is combined with Dacomitinib.]
[R03BB08, revefenacin, The metabolism of Dacomitinib can be decreased when combined with Revefenacin.]
[L01ED05, lorlatinib, The serum concentration of Dacomitinib can be decreased when it is combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Dacomitinib can be increased when combined with Emapalumab.]
[L01EX12, larotrectinib, The serum concentration of Larotrectinib can be increased when it is combined with Dacomitinib.]
[L01EX13, gilteritinib, The metabolism of Dacomitinib can be decreased when combined with Gilteritinib.]
[L01XJ03, glasdegib, The serum concentration of Dacomitinib can be increased when it is combined with Glasdegib.]
[A06AX05, prucalopride, The serum concentration of Prucalopride can be increased when it is combined with Dacomitinib.]
[B01AC23, cilostazol, The metabolism of Dacomitinib can be decreased when combined with Cilostazol.]
[P02BX04, triclabendazole, The metabolism of Dacomitinib can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Dacomitinib can be increased when combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Dacomitinib.]
[J01FA09, clarithromycin, The metabolism of Dacomitinib can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The serum concentration of Dacomitinib can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, The metabolism of Dacomitinib can be decreased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Dacomitinib can be increased when combined with Cloprednol.]
[C09CA06, candesartan, The metabolism of Dacomitinib can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Dacomitinib can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Dacomitinib can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Dacomitinib.]
[L02BB06, darolutamide, The serum concentration of Dacomitinib can be increased when it is combined with Darolutamide.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Dacomitinib.]
[L01EJ02, fedratinib, The serum concentration of Dacomitinib can be increased when it is combined with Fedratinib.]
[L01EX14, entrectinib, The serum concentration of Dacomitinib can be increased when it is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Pitolisant can be increased when it is combined with Dacomitinib.]
[J04AK08, pretomanid, The metabolism of Dacomitinib can be decreased when combined with Pretomanid.]
[J01XX12, lefamulin, Dacomitinib may decrease the excretion rate of Lefamulin which could result in a higher serum level.]
[N04CX01, istradefylline, The serum concentration of Dacomitinib can be increased when it is combined with Istradefylline.]
[G04BE04, yohimbine, The metabolism of Dacomitinib can be decreased when combined with Yohimbine.]
[J01XX09, daptomycin, The serum concentration of Daptomycin can be increased when it is combined with Dacomitinib.]
[J01DB01, cephalexin, The metabolism of Dacomitinib can be decreased when combined with Cephalexin.]
[J01DB09, cephradine, The metabolism of Dacomitinib can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Dacomitinib can be increased when combined with Deflazacort.]
[N02CC08, lasmiditan, The serum concentration of Dacomitinib can be increased when it is combined with Lasmiditan.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Dacomitinib.]
[G03AC09, desogestrel, The metabolism of Dacomitinib can be decreased when combined with Desogestrel.]
[B06AX03, voxelotor, The serum concentration of Dacomitinib can be increased when it is combined with Voxelotor.]
[N03AX25, cenobamate, The serum concentration of Dacomitinib can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Dacomitinib can be increased when it is combined with Givosiran.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Dacomitinib.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Dacomitinib.]
[R06AB02, dexchlorpheniramine, The metabolism of Dacomitinib can be decreased when combined with Dexchlorpheniramine.]
[L01EX18, avapritinib, The metabolism of Dacomitinib can be decreased when combined with Avapritinib.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Dacomitinib.]
[L01XX72, tazemetostat, The metabolism of Dacomitinib can be decreased when combined with Tazemetostat.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be increased when it is combined with Dacomitinib.]
[M01AX21, diacetylrhein, The metabolism of Dacomitinib can be decreased when combined with Diacerein.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Dacomitinib.]
[J05AB16, remdesivir, The metabolism of Dacomitinib can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Dacomitinib can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Dacomitinib can be decreased when combined with Amprenavir.]
[L04AA38, ozanimod, Dacomitinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, Dacomitinib may decrease the excretion rate of Selumetinib which could result in a higher serum level.]
[N02AA08, dihydrocodeine, The metabolism of Dacomitinib can be decreased when combined with Dihydrocodeine.]
[N02CC06, eletriptan, The metabolism of Dacomitinib can be decreased when combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Dacomitinib can be increased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Dacomitinib can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Dacomitinib can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Dacomitinib can be increased when it is combined with Dronedarone.]
[J01FA13, dirithromycin, The metabolism of Dacomitinib can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Dacomitinib can be decreased when combined with Chloramphenicol.]
[L01FX17, sacituzumab govitecan, The serum concentration of Sacituzumab govitecan can be increased when it is combined with Dacomitinib.]
[L01EH03, tucatinib, Tucatinib may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L01EX17, capmatinib, The serum concentration of Dacomitinib can be increased when it is combined with Capmatinib.]
[D07XB03, fluprednidene, The metabolism of Dacomitinib can be increased when combined with Fluprednidene.]
[G04BD09, trospium, The metabolism of Dacomitinib can be decreased when combined with Trospium.]
[L01EX19, ripretinib, The serum concentration of Dacomitinib can be increased when it is combined with Ripretinib.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Dyclonine.]
[R06AX22, ebastine, The metabolism of Dacomitinib can be decreased when combined with Ebastine.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[P01BB01, proguanil, The metabolism of Dacomitinib can be decreased when combined with Proguanil.]
[L01FX15, belantamab mafodotin, The serum concentration of Belantamab mafodotin can be increased when it is combined with Dacomitinib.]
[L04AC19, satralizumab, The serum concentration of Dacomitinib can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be increased when it is combined with Dacomitinib.]
[P01BA01, chloroquine, The metabolism of Dacomitinib can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be increased when it is combined with Dacomitinib.]
[R06AB04, chlorpheniramine, The metabolism of Dacomitinib can be decreased when combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The metabolism of Dacomitinib can be decreased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, The metabolism of Dacomitinib can be decreased when combined with Chlorpropamide.]
[M03BB03, chlorzoxazone, The metabolism of Dacomitinib can be decreased when combined with Chlorzoxazone.]
[A11CC05, cholecalciferol, The metabolism of Dacomitinib can be decreased when combined with Cholecalciferol.]
[N02BA03, choline salicylate, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Choline salicylate.]
[M01AB08, etodolac, The metabolism of Dacomitinib can be decreased when combined with Etodolac.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Dacomitinib.]
[A16AX20, lonafarnib, The metabolism of Dacomitinib can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Dacomitinib.]
[J05AJ04, cabotegravir, The metabolism of Cabotegravir can be decreased when combined with Dacomitinib.]
[L04AD03, voclosporin, The serum concentration of Dacomitinib can be increased when it is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Dacomitinib can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be increased when it is combined with Dacomitinib.]
[L01EX25, umbralisib, The serum concentration of Dacomitinib can be increased when it is combined with Umbralisib.]
[V03AF12, trilaciclib, Dacomitinib may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[N03AX10, felbamate, The metabolism of Dacomitinib can be increased when combined with Felbamate.]
[R03BA03, flunisolide, The metabolism of Dacomitinib can be increased when combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The metabolism of Dacomitinib can be increased when combined with Fluocinolone acetonide.]
[R03CC15, formoterol, The metabolism of Dacomitinib can be decreased when combined with Formoterol.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be decreased when combined with Dacomitinib.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L03AB10, peginterferon alfa-2b, The metabolism of Dacomitinib can be decreased when combined with Peginterferon alfa-2b.]
[G03GA06, follitropin beta, The therapeutic efficacy of Follitropin can be decreased when used in combination with Dacomitinib.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Dacomitinib.]
[A02BA01, cimetidine, The metabolism of Dacomitinib can be decreased when combined with Cimetidine.]
[N07CA02, cinnarizine, The metabolism of Dacomitinib can be decreased when combined with Cinnarizine.]
[L01XX73, sotorasib, The serum concentration of Dacomitinib can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Dacomitinib can be decreased when combined with Infigratinib.]
[S03AA07, ciprofloxacin, The metabolism of Dacomitinib can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The metabolism of Dacomitinib can be decreased when combined with Citalopram.]
[L04AA48, belumosudil, The serum concentration of Dacomitinib can be increased when it is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Dacomitinib can be decreased when combined with Fexinidazole.]
[L01XX74, belzutifan, The serum concentration of Dacomitinib can be decreased when it is combined with Belzutifan.]
[L01EB10, mobocertinib, The serum concentration of Dacomitinib can be decreased when it is combined with Mobocertinib.]
[L04AA59, avacopan, The metabolism of Dacomitinib can be decreased when combined with Avacopan.]
[R06AA04, clemastine, The metabolism of Dacomitinib can be decreased when combined with Clemastine.]
[M01AG01, mefenamic acid, The metabolism of Dacomitinib can be decreased when combined with Mefenamic acid.]
[A10BB12, glimepiride, The metabolism of Dacomitinib can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Dacomitinib can be decreased when combined with Gliquidone.]
[N06AX25, St. John's wort extract, The serum concentration of Dacomitinib can be decreased when it is combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Dacomitinib can be increased when it is combined with Asciminib.]
[J05AX10, maribavir, The serum concentration of Dacomitinib can be increased when it is combined with Maribavir.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Dacomitinib can be decreased when combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The serum concentration of Dacomitinib can be increased when it is combined with Abrocitinib.]
[J04BA01, clofazimine, The serum concentration of Dacomitinib can be increased when it is combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Dacomitinib can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Dacomitinib can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Dacomitinib can be increased when it is combined with Pacritinib.]
[G03GB02, clomiphene, The serum concentration of Clomifene can be increased when it is combined with Dacomitinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Dacomitinib.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Dacomitinib.]
[C01EB24, mavacamten, The serum concentration of Dacomitinib can be decreased when it is combined with Mavacamten.]
[J02AC06, oteseconazole, The serum concentration of Dacomitinib can be increased when it is combined with Oteseconazole.]
[A04AA01, ondansetron, The metabolism of Dacomitinib can be decreased when combined with Ondansetron.]
[J05AX31, lenacapavir, The metabolism of Dacomitinib can be decreased when combined with Lenacapavir.]
[N05AH02, clozapine, The metabolism of Dacomitinib can be decreased when combined with Clozapine.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be increased when it is combined with Dacomitinib.]
[A10BK06, sotagliflozin, The serum concentration of Dacomitinib can be increased when it is combined with Sotagliflozin.]
[H01AC08, somatrogon, The metabolism of Dacomitinib can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Dacomitinib can be increased when combined with Bimekizumab.]
[R05DA04, codeine, The metabolism of Dacomitinib can be decreased when combined with Codeine.]
[M04AC01, colchicine, The serum concentration of Colchicine can be increased when it is combined with Dacomitinib.]
[L04AA13, leflunomide, The metabolism of Dacomitinib can be decreased when combined with Leflunomide.]
[A10BX03, nateglinide, The metabolism of Dacomitinib can be decreased when combined with Nateglinide.]
[J01FA15, telithromycin, The metabolism of Dacomitinib can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Dacomitinib can be decreased when combined with Ciclesonide.]
[M01AH03, valdecoxib, The metabolism of Dacomitinib can be decreased when combined with Valdecoxib.]
[N02CC05, almotriptan, The metabolism of Dacomitinib can be decreased when combined with Almotriptan.]
[M01AH04, parecoxib, The metabolism of Dacomitinib can be decreased when combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Dacomitinib can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Acyclovir.]
[N05BA10, ketazolam, The metabolism of Dacomitinib can be decreased when combined with Ketazolam.]
[L02BA03, fulvestrant, The metabolism of Fulvestrant can be decreased when combined with Dacomitinib.]
[L01EA01, imatinib, The serum concentration of Dacomitinib can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Dacomitinib can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, Esomeprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dacomitinib.]
[N03AX09, lamotrigine, The metabolism of Lamotrigine can be decreased when combined with Dacomitinib.]
[S01BA03, cortisone, The metabolism of Dacomitinib can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The metabolism of Dacomitinib can be decreased when combined with Lofexidine.]
[C08CA11, manidipine, The metabolism of Dacomitinib can be decreased when combined with Manidipine.]
[C07AA14, mepindolol, The metabolism of Dacomitinib can be decreased when combined with Mepindolol.]
[H02AB15, meprednisone, The metabolism of Dacomitinib can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Dacomitinib can be decreased when combined with Mequitazine.]
[R06AE03, cyclizine, The metabolism of Dacomitinib can be decreased when combined with Cyclizine.]
[N05AD03, metylperon, The metabolism of Dacomitinib can be decreased when combined with Melperone.]
[J01FA03, midecamycin, The metabolism of Dacomitinib can be decreased when combined with Midecamycin.]
[J05AF07, tenofovir disoproxil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Dacomitinib.]
[L01AA01, cyclophosphamide, The metabolism of Dacomitinib can be increased when combined with Cyclophosphamide.]
[N06AX07, minaprine, The metabolism of Dacomitinib can be decreased when combined with Minaprine.]
[S01XA18, cyclosporine, The metabolism of Dacomitinib can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The metabolism of Dacomitinib can be decreased when combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Dacomitinib can be increased when combined with Modafinil.]
[C10AA07, rosuvastatin, The metabolism of Dacomitinib can be decreased when combined with Rosuvastatin.]
[C03XA02, conivaptan, The metabolism of Dacomitinib can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Cytarabine.]
[G04BE09, vardenafil, The serum concentration of Dacomitinib can be increased when it is combined with Vardenafil.]
[M01AH05, etoricoxib, The metabolism of Dacomitinib can be decreased when combined with Etoricoxib.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be increased when it is combined with Dacomitinib.]
[G03XA01, danazol, The metabolism of Dacomitinib can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Dacomitinib can be increased when combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Dacomitinib can be decreased when combined with Daunorubicin.]
[C02CC04, debrisoquin, The metabolism of Dacomitinib can be decreased when combined with Debrisoquine.]
[A04AD11, nabilone, The metabolism of Dacomitinib can be decreased when combined with Nabilone.]
[M01AX01, nabumetone, The metabolism of Dacomitinib can be decreased when combined with Nabumetone.]
[C07AB12, nebivolol, The metabolism of Dacomitinib can be decreased when combined with Nebivolol.]
[N06AX06, nefazodone, The metabolism of Dacomitinib can be decreased when combined with Nefazodone.]
[L02BB02, nilutamide, The metabolism of Dacomitinib can be decreased when combined with Nilutamide.]
[N03AG06, tiagabine, The metabolism of Tiagabine can be decreased when combined with Dacomitinib.]
[N06AB10, escitalopram, The serum concentration of Dacomitinib can be increased when it is combined with Escitalopram.]
[G04BD08, solifenacin, The metabolism of Dacomitinib can be decreased when combined with Solifenacin.]
[N06AA01, desipramine, The metabolism of Dacomitinib can be decreased when combined with Desipramine.]
[L01XA03, oxaliplatin, Dacomitinib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The metabolism of Dacomitinib can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Dacomitinib can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Dacomitinib can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dacomitinib can be decreased when combined with Dexfenfluramine.]
[L04AB04, adalimumab, The metabolism of Dacomitinib can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Dacomitinib can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, The metabolism of Dacomitinib can be decreased when combined with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Dacomitinib can be decreased when combined with Dextromethorphan.]
[N03AC01, paramethadione, The metabolism of Dacomitinib can be decreased when combined with Paramethadione.]
[H05AA02, teriparatide, The therapeutic efficacy of Teriparatide can be decreased when used in combination with Dacomitinib.]
[N06AB05, paroxetine, The metabolism of Dacomitinib can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Dacomitinib can be decreased when combined with Clopidogrel.]
[N05BA01, diazepam, The metabolism of Dacomitinib can be decreased when combined with Diazepam.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Cinchocaine.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Dacomitinib.]
[J01CF01, dicloxacillin, The metabolism of Dacomitinib can be increased when combined with Dicloxacillin.]
[L01DC04, ixabepilone, The serum concentration of Dacomitinib can be increased when it is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Dacomitinib can be decreased when combined with Erlotinib.]
[L02AA01, diethylstilbestrol, The metabolism of Dacomitinib can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Dacomitinib can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Dacomitinib can be increased when combined with Difluocortolone.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Dacomitinib.]
[C01AA05, digoxin, Dacomitinib may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C10AX09, ezetimibe, Dacomitinib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[C04AE04, dihydroergocristine, The metabolism of Dacomitinib can be decreased when combined with Dihydroergocristine.]
[N02CA01, dihydroergotamine, The metabolism of Dacomitinib can be decreased when combined with Dihydroergotamine.]
[N02AA03, hydromorphone, The metabolism of Dacomitinib can be decreased when combined with Hydromorphone.]
[J05AE08, atazanavir, The metabolism of Dacomitinib can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Dacomitinib can be decreased when combined with Treprostinil.]
[H03BC01, potassium perchlorate, The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Dacomitinib.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Dacomitinib can be decreased when combined with Diltiazem.]
[M02AX03, dimethyl sulfoxide, The metabolism of Dacomitinib can be decreased when combined with Dimethyl sulfoxide.]
[C05CA03, diosmin, The serum concentration of Dacomitinib can be increased when it is combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Dacomitinib can be decreased when combined with Quazepam.]
[A03FA02, cisapride, The metabolism of Dacomitinib can be decreased when combined with Cisapride.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be increased when it is combined with Dacomitinib.]
[N05AL04, remoxipride, The metabolism of Dacomitinib can be decreased when combined with Remoxipride.]
[S02AA12, rifamycin SV, The serum concentration of Dacomitinib can be increased when it is combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Dacomitinib can be increased when combined with Rifapentine.]
[D06AX11, rifaximin, The serum concentration of Rifaximin can be increased when it is combined with Dacomitinib.]
[N07XX02, riluzole, Dacomitinib may decrease the excretion rate of Riluzole which could result in a higher serum level.]
[N05AX08, risperidone, The metabolism of Dacomitinib can be decreased when combined with Risperidone.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Ropivacaine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Dacomitinib.]
[A04AD12, aprepitant, The metabolism of Dacomitinib can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be increased when it is combined with Dacomitinib.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Dacomitinib.]
[J05AE07, fosamprenavir, The metabolism of Dacomitinib can be decreased when combined with Fosamprenavir.]
[S01BC05, ketorolac, The metabolism of Dacomitinib can be decreased when combined with Ketorolac.]
[C02KX02, ambrisentan, The serum concentration of Ambrisentan can be increased when it is combined with Dacomitinib.]
[C01EB18, ranolazine, The serum concentration of Ranolazine can be increased when it is combined with Dacomitinib.]
[R03AC12, salmeterol, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Salmeterol.]
[H05BA01, salmon calcitonin, The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dacomitinib.]
[A03FA03, domperidone, The metabolism of Dacomitinib can be decreased when combined with Domperidone.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Dopamine.]
[N06AA16, dothiepin, The metabolism of Dacomitinib can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Dacomitinib can be decreased when combined with Doxepin.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be increased when it is combined with Dacomitinib.]
[N06AB06, sertraline, The metabolism of Dacomitinib can be decreased when combined with Sertraline.]
[C10AA01, simvastatin, The serum concentration of Dacomitinib can be increased when it is combined with Simvastatin.]
[N02CC01, sumatriptan, Dacomitinib may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[C07AB13, talinolol, The metabolism of Dacomitinib can be decreased when combined with Talinolol.]
[H01AA01, corticotropin, The metabolism of Dacomitinib can be increased when combined with Corticotropin.]
[M01AC02, tenoxicam, The metabolism of Dacomitinib can be decreased when combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Dacomitinib can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Dacomitinib can be decreased when combined with Tertatolol.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Dacomitinib.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Dacomitinib.]
[N03AX11, topiramate, The metabolism of Dacomitinib can be increased when combined with Topiramate.]
[L02BA02, toremifene, The serum concentration of Dacomitinib can be increased when it is combined with Toremifene.]
[C03CA04, torsemide, The metabolism of Dacomitinib can be decreased when combined with Torasemide.]
[G03GA05, follitropin alfa, The therapeutic efficacy of Follitropin can be decreased when used in combination with Dacomitinib.]
[L01CA04, vinorelbine, The metabolism of Dacomitinib can be decreased when combined with Vinorelbine.]
[S01GX10, epinastine, The metabolism of Dacomitinib can be decreased when combined with Epinastine.]
[N06AX16, venlafaxine, The metabolism of Dacomitinib can be decreased when combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Dacomitinib can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Dacomitinib can be decreased when combined with Epinephrine.]
[N05CF02, zolpidem, The metabolism of Dacomitinib can be decreased when combined with Zolpidem.]
[N03AX15, zonisamide, The serum concentration of Dacomitinib can be increased when it is combined with Zonisamide.]
[N05CF01, zopiclone, The metabolism of Dacomitinib can be decreased when combined with Zopiclone.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Guanfacine.]
[N02CA02, ergotamine, The metabolism of Dacomitinib can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The serum concentration of Dacomitinib can be increased when it is combined with Erythromycin.]
[A02BC02, pantoprazole, Pantoprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H05BX01, cinacalcet, The metabolism of Dacomitinib can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Dacomitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[J04AK02, ethambutol, The metabolism of Dacomitinib can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Dacomitinib can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Dacomitinib can be increased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Dacomitinib can be decreased when combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Dacomitinib.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Meloxicam.]
[S01XA06, ethylmorphine, The metabolism of Dacomitinib can be decreased when combined with Ethylmorphine.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Etidocaine.]
[L01CB01, etoposide, The serum concentration of Etoposide can be increased when it is combined with Dacomitinib.]
[N05AE03, sertindole, The metabolism of Dacomitinib can be decreased when combined with Sertindole.]
[L04AD02, tacrolimus, The serum concentration of Dacomitinib can be increased when it is combined with Tacrolimus.]
[R06AX11, astemizole, The metabolism of Dacomitinib can be decreased when combined with Astemizole.]
[R06AX12, terfenadine, The metabolism of Dacomitinib can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Dacomitinib can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The metabolism of Dacomitinib can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Dacomitinib can be decreased when combined with Encainide.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Dacomitinib can be decreased when combined with Albendazole.]
[C08CA02, felodipine, The metabolism of Dacomitinib can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The metabolism of Dacomitinib can be decreased when combined with Fenfluramine.]
[L01BB06, clofarabine, Dacomitinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA40, cladribine, Dacomitinib may decrease the excretion rate of Cladribine which could result in a higher serum level.]
[N07AX03, cevimeline, The metabolism of Dacomitinib can be decreased when combined with Cevimeline.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Dacomitinib.]
[J01CF05, floxacillin, The metabolism of Dacomitinib can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The serum concentration of Dacomitinib can be increased when it is combined with Fluconazole.]
[N07CA03, flunarizine, The metabolism of Dacomitinib can be decreased when combined with Flunarizine.]
[N05CD03, flunitrazepam, The metabolism of Dacomitinib can be decreased when combined with Flunitrazepam.]
[D07AC08, fluocinonide, The metabolism of Dacomitinib can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Dacomitinib can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Dacomitinib can be increased when combined with Ethanol.]
[L01BC09, floxuridine, The metabolism of Dacomitinib can be decreased when combined with Floxuridine.]
[L01BC02, fluorouracil, The metabolism of Dacomitinib can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The serum concentration of Dacomitinib can be increased when it is combined with Fluoxetine.]
[N05AB02, fluphenazine, The metabolism of Dacomitinib can be decreased when combined with Fluphenazine.]
[S01BC04, flurbiprofen, The metabolism of Flurbiprofen can be decreased when combined with Dacomitinib.]
[V04CX02, folic acid, Dacomitinib may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[J05AE10, darunavir, The serum concentration of Dacomitinib can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, The metabolism of Furosemide can be decreased when combined with Dacomitinib.]
[N06DA04, galantamine, The metabolism of Dacomitinib can be decreased when combined with Galantamine.]
[S01AD09, ganciclovir, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Ganciclovir.]
[N03AA04, barbexaclone, The metabolism of Dacomitinib can be increased when combined with Barbexaclone.]
[C10AB04, gemfibrozil, The metabolism of Dacomitinib can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be increased when it is combined with Dacomitinib.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be increased when it is combined with Dacomitinib.]
[J05AG04, etravirine, The metabolism of Dacomitinib can be increased when combined with Etravirine.]
[L01EH01, lapatinib, The serum concentration of Dacomitinib can be increased when it is combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Dacomitinib can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Dacomitinib can be decreased when combined with Gliclazide.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Dacomitinib.]
[N05CM18, dexmedetomidine, The metabolism of Dacomitinib can be decreased when combined with Dexmedetomidine.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Dacomitinib.]
[C02CA04, doxazosin, The metabolism of Dacomitinib can be decreased when combined with Doxazosin.]
[H01AB01, thyrotropin alfa, The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dacomitinib.]
[L01EX02, sorafenib, The serum concentration of Dacomitinib can be increased when it is combined with Sorafenib.]
[C07AB09, esmolol, The metabolism of Dacomitinib can be decreased when combined with Esmolol.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Dacomitinib.]
[D01BA01, griseofulvin, The metabolism of Dacomitinib can be increased when combined with Griseofulvin.]
[P01BX01, halofantrine, The metabolism of Dacomitinib can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Dacomitinib.]
[N01AB01, halothane, The metabolism of Dacomitinib can be decreased when combined with Halothane.]
[N05AH04, quetiapine, The metabolism of Dacomitinib can be decreased when combined with Quetiapine.]
[L01CE02, irinotecan, The risk or severity of neutropenia can be increased when Dacomitinib is combined with Irinotecan.]
[M04AA01, allopurinol, Dacomitinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C09CA01, losartan, The metabolism of Dacomitinib can be decreased when combined with Losartan.]
[G03DC01, allylestrenol, The metabolism of Dacomitinib can be decreased when combined with Allylestrenol.]
[N05CA16, hexobarbital, The metabolism of Dacomitinib can be decreased when combined with Hexobarbital.]
[J05AG01, nevirapine, The metabolism of Dacomitinib can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Dacomitinib can be decreased when combined with Nilvadipine.]
[C02DB02, hydralazine, The metabolism of Dacomitinib can be decreased when combined with Hydralazine.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Dacomitinib.]
[S02BA01, hydrocortisone, The metabolism of Dacomitinib can be increased when combined with Hydrocortisone.]
[P01BA02, hydroxychloroquine, The metabolism of Dacomitinib can be decreased when combined with Hydroxychloroquine.]
[N05BB01, hydroxyzine, The metabolism of Dacomitinib can be decreased when combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Dacomitinib can be increased when combined with Rifabutin.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Dacomitinib.]
[L01DB06, idarubicin, The metabolism of Dacomitinib can be decreased when combined with Idarubicin.]
[L01AA06, ifosfamide, The metabolism of Dacomitinib can be increased when combined with Ifosfamide.]
[N06AA02, imipramine, The metabolism of Dacomitinib can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Dacomitinib can be increased when combined with Paclitaxel.]
[L01CE01, topotecan, The serum concentration of Topotecan can be increased when it is combined with Dacomitinib.]
[S01BC01, indomethacin, The metabolism of Indomethacin can be decreased when combined with Dacomitinib.]
[N06AX17, milnacipran, The metabolism of Dacomitinib can be decreased when combined with Milnacipran.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Articaine.]
[A10BH01, sitagliptin, The serum concentration of Sitagliptin can be increased when it is combined with Dacomitinib.]
[N05CH02, ramelteon, The metabolism of Dacomitinib can be decreased when combined with Ramelteon.]
[C10AA06, cerivastatin, The metabolism of Dacomitinib can be increased when combined with Cerivastatin.]
[C07AA01, alprenolol, The metabolism of Dacomitinib can be decreased when combined with Alprenolol.]
[V03AB01, ipecac, The metabolism of Dacomitinib can be decreased when combined with Ipecac.]
[N06AF05, iproniazid, The metabolism of Dacomitinib can be decreased when combined with Iproniazid.]
[P01AX06, atovaquone, The metabolism of Dacomitinib can be decreased when combined with Atovaquone.]
[N04BX02, entacapone, The metabolism of Dacomitinib can be decreased when combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Dacomitinib can be decreased when combined with Isoniazid.]
[P02CF01, ivermectin, Dacomitinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[N06AX18, reboxetine, The metabolism of Dacomitinib can be decreased when combined with Reboxetine.]
[L04AC07, tocilizumab, The metabolism of Dacomitinib can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Dacomitinib can be decreased when combined with Ketamine.]
[B01AC22, prasugrel, The metabolism of Dacomitinib can be decreased when combined with Prasugrel.]
[J02AB02, ketoconazole, The metabolism of Dacomitinib can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Dacomitinib can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, The metabolism of Dacomitinib can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, The metabolism of Ketoprofen can be decreased when combined with Dacomitinib.]
[V03AC03, deferasirox, The metabolism of Dacomitinib can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Dacomitinib can be increased when combined with Abatacept.]
[N04BC09, rotigotine, The metabolism of Dacomitinib can be decreased when combined with Rotigotine.]
[C07AG01, labetalol, The metabolism of Dacomitinib can be decreased when combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Amantadine.]
[N03AX18, lacosamide, The metabolism of Dacomitinib can be decreased when combined with Lacosamide.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Lidocaine.]
[N06BA13, armodafinil, The metabolism of Dacomitinib can be increased when combined with Armodafinil.]
[N02CA07, lisuride, The metabolism of Dacomitinib can be decreased when combined with Lisuride.]
[A07DA03, loperamide, The excretion of Loperamide can be decreased when combined with Dacomitinib.]
[C10AA02, lovastatin, The metabolism of Dacomitinib can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The serum concentration of Dacomitinib can be increased when it is combined with Loxapine.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Dacomitinib.]
[L01EG01, temsirolimus, The serum concentration of Dacomitinib can be increased when it is combined with Temsirolimus.]
[L01BA05, pralatrexate, Dacomitinib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Dacomitinib can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The serum concentration of Mannitol can be increased when it is combined with Dacomitinib.]
[N06AA21, maprotiline, The metabolism of Dacomitinib can be decreased when combined with Maprotiline.]
[R06AE05, meclizine, The metabolism of Dacomitinib can be decreased when combined with Meclizine.]
[C01AA08, medigoxin, Dacomitinib may decrease the excretion rate of Metildigoxin which could result in a higher serum level.]
[P01BC02, mefloquine, The serum concentration of Dacomitinib can be increased when it is combined with Mefloquine.]
[N02AB02, meperidine, The metabolism of Dacomitinib can be decreased when combined with Meperidine.]
[N03AB04, mephenytoin, The metabolism of Dacomitinib can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, The metabolism of Dacomitinib can be increased when combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Mepivacaine.]
[L02BG01, aminoglutethimide, The metabolism of Dacomitinib can be increased when combined with Aminoglutethimide.]
[N05AC03, mesoridazine, The metabolism of Dacomitinib can be decreased when combined with Mesoridazine.]
[N05AX13, paliperidone, The serum concentration of Dacomitinib can be increased when it is combined with Paliperidone.]
[A04AA04, dolasetron, The metabolism of Dacomitinib can be decreased when combined with Dolasetron.]
[H01CB03, lanreotide, The metabolism of Dacomitinib can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Dacomitinib can be decreased when combined with Methadone.]
[N06BA03, methamphetamine, The metabolism of Dacomitinib can be decreased when combined with Metamfetamine.]
[J05AF05, lamivudine, Dacomitinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[H03BB02, methimazole, The metabolism of Dacomitinib can be decreased when combined with Methimazole.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Dacomitinib.]
[N05AA02, methotrimeprazine, The metabolism of Dacomitinib can be decreased when combined with Methotrimeprazine.]
[N02BG09, methoxyflurane, The metabolism of Dacomitinib can be decreased when combined with Methoxyflurane.]
[V04CG05, methylene blue, The serum concentration of Dacomitinib can be increased when it is combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Dacomitinib can be decreased when combined with Methylergometrine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Dacomitinib.]
[H02AB04, methylprednisolone, The metabolism of Dacomitinib can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The metabolism of Dacomitinib can be increased when combined with Rufinamide.]
[N02CA04, methysergide, The metabolism of Dacomitinib can be decreased when combined with Methysergide.]
[A03FA01, metoclopramide, The metabolism of Dacomitinib can be decreased when combined with Metoclopramide.]
[C07AB02, metoprolol, The metabolism of Dacomitinib can be decreased when combined with Metoprolol.]
[P01AB01, metronidazole, The metabolism of Dacomitinib can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Dacomitinib can be increased when combined with Metyrapone.]
[C01BB02, mexiletine, The metabolism of Dacomitinib can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The metabolism of Dacomitinib can be decreased when combined with Mianserin.]
[S02AA13, miconazole, The metabolism of Dacomitinib can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Dacomitinib can be decreased when combined with Aminophenazone.]
[N05CD08, midazolam, The metabolism of Dacomitinib can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The serum concentration of Dacomitinib can be decreased when it is combined with Mifepristone.]
[C09CA03, valsartan, The metabolism of Dacomitinib can be decreased when combined with Valsartan.]
[D11AX01, minoxidil, The metabolism of Minoxidil can be decreased when combined with Dacomitinib.]
[J01FA11, miocamycin, The metabolism of Dacomitinib can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Dacomitinib can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, Dacomitinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.]
[N06BA12, lisdexamfetamine, The metabolism of Dacomitinib can be decreased when combined with Lisdexamfetamine.]
[L03AC01, aldesleukin, The metabolism of Dacomitinib can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Dacomitinib can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Dacomitinib.]
[N02AA01, morphine, The serum concentration of Morphine can be increased when it is combined with Dacomitinib.]
[A04AA05, palonosetron, The metabolism of Dacomitinib can be decreased when combined with Palonosetron.]
[L04AB05, certolizumab pegol, The metabolism of Dacomitinib can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Dacomitinib.]
[L04AA06, mycophenolic acid, The metabolism of Mycophenolic acid can be decreased when combined with Dacomitinib.]
[N05CA02, amobarbital, The metabolism of Dacomitinib can be increased when combined with Amobarbital.]
[J05AJ01, raltegravir, The metabolism of Raltegravir can be decreased when combined with Dacomitinib.]
[P01BA06, amodiaquine, The metabolism of Dacomitinib can be decreased when combined with Amodiaquine.]
[G04CA04, silodosin, The excretion of Silodosin can be decreased when combined with Dacomitinib.]
[G03XC01, raloxifene, The metabolism of Dacomitinib can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Dacomitinib.]
[N03AB05, fosphenytoin, The metabolism of Dacomitinib can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, The metabolism of Dacomitinib can be decreased when combined with Nadolol.]
[J01CF06, nafcillin, The metabolism of Dacomitinib can be increased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Dacomitinib can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The metabolism of Naltrexone can be decreased when combined with Dacomitinib.]
[L04AC03, anakinra, The metabolism of Dacomitinib can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Dacomitinib can be decreased when combined with Amphetamine.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Dacomitinib.]
[A10BG01, troglitazone, The metabolism of Dacomitinib can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Dacomitinib can be decreased when combined with Duloxetine.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Dacomitinib.]
[L01CD02, docetaxel, The metabolism of Dacomitinib can be decreased when combined with Docetaxel.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Dacomitinib.]
[N06AX23, desvenlafaxine, The metabolism of Dacomitinib can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Dacomitinib can be decreased when combined with Febuxostat.]
[C10AD02, niacin, The metabolism of Dacomitinib can be decreased when combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Dacomitinib can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The metabolism of Dacomitinib can be decreased when combined with Nicergoline.]
[P02DA01, niclosamide, The metabolism of Dacomitinib can be decreased when combined with Niclosamide.]
[C08CA05, nifedipine, The metabolism of Dacomitinib can be decreased when combined with Nifedipine.]
[J01XE01, nitrofurantoin, Dacomitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Pramipexole.]
[C01CA03, norepinephrine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Norepinephrine.]
[G03DC02, norethindrone, The metabolism of Dacomitinib can be decreased when combined with Norethisterone.]
[C02KX01, bosentan, The metabolism of Dacomitinib can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be increased when it is combined with Dacomitinib.]
[R05DA07, noscapine, The metabolism of Dacomitinib can be decreased when combined with Noscapine.]
[A16AX07, sapropterin, The serum concentration of Dacomitinib can be increased when it is combined with Sapropterin.]
[H01CB02, octreotide, The serum concentration of Dacomitinib can be increased when it is combined with Octreotide.]
[J01FA05, oleandomycin, The metabolism of Dacomitinib can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Dacomitinib can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, Omeprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02AA02, opium, The metabolism of Dacomitinib can be decreased when combined with Opium.]
[G04CA02, tamsulosin, The metabolism of Dacomitinib can be decreased when combined with Tamsulosin.]
[P02BA02, oxamniquine, The metabolism of Dacomitinib can be decreased when combined with Oxamniquine.]
[A14AA08, oxandrolone, The metabolism of Dacomitinib can be decreased when combined with Oxandrolone.]
[C07AA02, oxprenolol, The metabolism of Dacomitinib can be decreased when combined with Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Dacomitinib can be decreased when combined with Oxycodone.]
[N02AA11, oxymorphone, The metabolism of Dacomitinib can be decreased when combined with Oxymorphone.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Pancuronium.]
[H02AB05, paramethasone, The metabolism of Dacomitinib can be increased when combined with Paramethasone.]
[G04BD11, fesoterodine, The metabolism of Dacomitinib can be decreased when combined with Fesoterodine.]
[C07AA23, penbutolol, The metabolism of Dacomitinib can be decreased when combined with Penbutolol.]
[N05CA01, pentobarbital, The metabolism of Dacomitinib can be increased when combined with Pentobarbital.]
[C08EX02, perhexiline, The metabolism of Dacomitinib can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The metabolism of Dacomitinib can be decreased when combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Dacomitinib can be decreased when combined with Phenacetin.]
[A10BA01, phenformin, The metabolism of Dacomitinib can be decreased when combined with Phenformin.]
[N03AA02, phenobarbital, The metabolism of Dacomitinib can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Dacomitinib.]
[M02AA01, phenylbutazone, The metabolism of Dacomitinib can be increased when combined with Phenylbutazone.]
[A02BC06, dexlansoprazole, Dexlansoprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N03AB02, phenytoin, The metabolism of Dacomitinib can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Dacomitinib can be increased when combined with Golimumab.]
[L02BB03, bicalutamide, The metabolism of Dacomitinib can be decreased when combined with Bicalutamide.]
[C08CX01, mibefradil, The serum concentration of Dacomitinib can be increased when it is combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Dacomitinib.]
[C07AA03, pindolol, The metabolism of Dacomitinib can be decreased when combined with Pindolol.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Dacomitinib.]
[J05AE01, saquinavir, The metabolism of Dacomitinib can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Dacomitinib can be decreased when combined with Piperazine.]
[N05AC04, pipothiazine, The metabolism of Dacomitinib can be decreased when combined with Pipotiazine.]
[S01BC06, piroxicam, The metabolism of Dacomitinib can be decreased when combined with Piroxicam.]
[J05AG02, delavirdine, The metabolism of Dacomitinib can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Dacomitinib can be decreased when combined with Irbesartan.]
[A10BG02, rosiglitazone, The metabolism of Dacomitinib can be decreased when combined with Rosiglitazone.]
[A03AE01, alosetron, The metabolism of Dacomitinib can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Dacomitinib can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The serum concentration of Dacomitinib can be increased when it is combined with Ritonavir.]
[V03AB21, potassium iodide, The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Dacomitinib.]
[C10AA08, pitavastatin, Dacomitinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[C07AB01, practolol, The metabolism of Dacomitinib can be decreased when combined with Practolol.]
[C02CA01, prazosin, Dacomitinib may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[S03BA02, prednisolone, The metabolism of Dacomitinib can be increased when combined with Prednisolone.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Dacomitinib can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Dacomitinib can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Dacomitinib can be increased when combined with Probenecid.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Dacomitinib.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Procaine.]
[C10AB05, fenofibrate, The metabolism of Dacomitinib can be decreased when combined with Fenofibrate.]
[N05AB04, prochlorperazine, The metabolism of Dacomitinib can be decreased when combined with Prochlorperazine.]
[G03DA04, progesterone, The metabolism of Dacomitinib can be decreased when combined with Progesterone.]
[N05AA03, promazine, The metabolism of Dacomitinib can be decreased when combined with Promazine.]
[R06AD02, promethazine, The metabolism of Dacomitinib can be decreased when combined with Promethazine.]
[C01BC03, propafenone, The serum concentration of Dacomitinib can be increased when it is combined with Propafenone.]
[R06AX26, fexofenadine, The serum concentration of Fexofenadine can be increased when it is combined with Dacomitinib.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be increased when it is combined with Dacomitinib.]
[N01AX10, propofol, The metabolism of Dacomitinib can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Dacomitinib can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, The metabolism of Dacomitinib can be decreased when combined with Propranolol.]
[H03BA02, propylthiouracil, The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Dacomitinib.]
[R03DC03, montelukast, The metabolism of Dacomitinib can be decreased when combined with Montelukast.]
[N05AX12, aripiprazole, The metabolism of Dacomitinib can be decreased when combined with Aripiprazole.]
[R06AC01, pyrilamine, The metabolism of Dacomitinib can be decreased when combined with Mepyramine.]
[C01BA01, quinidine, The serum concentration of Dacomitinib can be increased when it is combined with Quinidine.]
[P01BC01, quinine, The metabolism of Dacomitinib can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Dacomitinib can be decreased when combined with Ranitidine.]
[C02AA02, reserpine, The serum concentration of Dacomitinib can be increased when it is combined with Reserpine.]
[J04AB02, rifampin, The serum concentration of Dacomitinib can be decreased when it is combined with Rifampicin.]
[J01FA06, roxithromycin, The metabolism of Dacomitinib can be decreased when combined with Roxithromycin.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[S01BC08, salicylic acid, The metabolism of Dacomitinib can be decreased when combined with Salicylic acid.]
[N05CA06, secobarbital, The metabolism of Dacomitinib can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Dacomitinib can be decreased when combined with Selegiline.]
[H01CB01, somatostatin, The metabolism of Dacomitinib can be decreased when combined with Somatostatin.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Dacomitinib.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be increased when it is combined with Dacomitinib.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be increased when it is combined with Dacomitinib.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Dacomitinib.]
[N03AG01, valproic acid, The metabolism of Dacomitinib can be decreased when combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Dacomitinib can be increased when combined with Hydrocortisone butyrate.]
[S02DA03, antipyrine, The metabolism of Dacomitinib can be decreased when combined with Antipyrine.]
[J01EC02, sulfadiazine, The metabolism of Dacomitinib can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Dacomitinib can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The metabolism of Dacomitinib can be decreased when combined with Sulfamethoxazole.]
[J01EC03, sulfamoxole, The metabolism of Dacomitinib can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Dacomitinib can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Dacomitinib can be increased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Dacomitinib can be decreased when combined with Sulfisoxazole.]
[A10BB04, glibornuride, The metabolism of Dacomitinib can be decreased when combined with Glibornuride.]
[L02BA01, tamoxifen, The serum concentration of Dacomitinib can be increased when it is combined with Tamoxifen.]
[L01CB02, teniposide, The metabolism of Dacomitinib can be decreased when combined with Teniposide.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Dacomitinib.]
[G03BA03, testosterone, The metabolism of Dacomitinib can be increased when combined with Testosterone.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Dacomitinib.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Tetracaine.]
[S03AA02, tetracycline, The metabolism of Dacomitinib can be decreased when combined with Tetracycline.]
[A04AD10, dronabinol, The metabolism of Dacomitinib can be decreased when combined with Dronabinol.]
[L04AX02, thalidomide, The metabolism of Dacomitinib can be decreased when combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Dacomitinib.]
[A11DA01, thiamine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Thiamine.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Dacomitinib.]
[N05AC02, thioridazine, The metabolism of Dacomitinib can be decreased when combined with Thioridazine.]
[C01BB04, aprindine, The metabolism of Dacomitinib can be decreased when combined with Aprindine.]
[V04CJ01, thyrotropin, The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Dacomitinib.]
[V04CJ02, thyrotropin-releasing hormone, The therapeutic efficacy of Protirelin can be decreased when used in combination with Dacomitinib.]
[B01AC05, ticlopidine, The metabolism of Dacomitinib can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Dacomitinib.]
[A10BB05, tolazamide, The metabolism of Dacomitinib can be decreased when combined with Tolazamide.]
[V04CA01, tolbutamide, The metabolism of Dacomitinib can be decreased when combined with Tolbutamide.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Dacomitinib.]
[N06AF04, tranylcypromine, The metabolism of Dacomitinib can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The serum concentration of Dacomitinib can be decreased when it is combined with Trazodone.]
[L01XF01, tretinoin, The metabolism of Dacomitinib can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The metabolism of Dacomitinib can be increased when combined with Triamcinolone.]
[R03BA07, mometasone, The metabolism of Dacomitinib can be increased when combined with Mometasone.]
[N03AC02, trimethadione, The metabolism of Dacomitinib can be decreased when combined with Trimethadione.]
[J01EA01, trimethoprim, The metabolism of Dacomitinib can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Dacomitinib.]
[R06AC04, tripelennamine, The metabolism of Dacomitinib can be decreased when combined with Tripelennamine.]
[J01FA08, troleandomycin, The metabolism of Dacomitinib can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Dacomitinib can be decreased when combined with Vilazodone.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Tubocurarine.]
[R03DX07, roflumilast, The metabolism of Dacomitinib can be decreased when combined with Roflumilast.]
[L01EX04, vandetanib, The serum concentration of Dacomitinib can be increased when it is combined with Vandetanib.]
[L02BX03, abiraterone, The metabolism of Dacomitinib can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The serum concentration of Dacomitinib can be increased when it is combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Dacomitinib can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Dacomitinib can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Dacomitinib can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, The metabolism of Ezogabine can be decreased when combined with Dacomitinib.]
[B01AF01, rivaroxaban, Dacomitinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, The serum concentration of Indacaterol can be increased when it is combined with Dacomitinib.]
[B01AC24, ticagrelor, The serum concentration of Dacomitinib can be increased when it is combined with Ticagrelor.]
[C08DA01, verapamil, The serum concentration of Dacomitinib can be increased when it is combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Dacomitinib can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be increased when it is combined with Dacomitinib.]
[L01CA02, vincristine, The excretion of Vincristine can be decreased when combined with Dacomitinib.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Dacomitinib.]
[A11HA03, vitamin E, The metabolism of Dacomitinib can be increased when combined with Vitamin E.]
[B01AA03, warfarin, The metabolism of Dacomitinib can be increased when combined with Warfarin.]
[J05AF01, zidovudine, Dacomitinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N05AF05, zuclopenthixol, The metabolism of Dacomitinib can be decreased when combined with Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Dacomitinib can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Dacomitinib can be increased when it is combined with Vemurafenib.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be increased when it is combined with Dacomitinib.]
[L01ED01, crizotinib, The metabolism of Dacomitinib can be decreased when combined with Crizotinib.]
[R03DC01, zafirlukast, The metabolism of Dacomitinib can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Rabeprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AE04, ziprasidone, The metabolism of Dacomitinib can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Dacomitinib can be decreased when combined with Drospirenone.]
[N02BA01, aspirin, The metabolism of Dacomitinib can be decreased when combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Dacomitinib.]
[G04BD07, tolterodine, The metabolism of Dacomitinib can be decreased when combined with Tolterodine.]
[C07AB03, atenolol, The metabolism of Dacomitinib can be decreased when combined with Atenolol.]
[J02AC03, voriconazole, The serum concentration of Dacomitinib can be increased when it is combined with Voriconazole.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L01EK01, axitinib, The serum concentration of Axitinib can be increased when it is combined with Dacomitinib.]
[R07AX02, ivacaftor, The serum concentration of Dacomitinib can be increased when it is combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Dacomitinib can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Dacomitinib.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Dacomitinib.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Dacomitinib.]
[A08AA11, lorcaserin, The metabolism of Dacomitinib can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Dacomitinib can be increased when it is combined with Mirabegron.]
[L01XG02, carfilzomib, The serum concentration of Dacomitinib can be increased when it is combined with Carfilzomib.]
[V03AX03, cobicistat, The metabolism of Dacomitinib can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Dacomitinib can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Dacomitinib can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Dacomitinib.]
[L04AA31, teriflunomide, Teriflunomide may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L01EX05, regorafenib, The serum concentration of Dacomitinib can be increased when it is combined with Regorafenib.]
[N05CA04, barbital, The metabolism of Dacomitinib can be increased when combined with Barbital.]
[J05AE04, nelfinavir, The metabolism of Dacomitinib can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Dacomitinib.]
[N06DA02, donepezil, The metabolism of Dacomitinib can be decreased when combined with Donepezil.]
[N03AX22, perampanel, The metabolism of Dacomitinib can be increased when combined with Perampanel.]
[G04BD10, darifenacin, The metabolism of Dacomitinib can be decreased when combined with Darifenacin.]
[L01EX07, cabozantinib, The metabolism of Dacomitinib can be decreased when combined with Cabozantinib.]
[H01CB05, pasireotide, The metabolism of Dacomitinib can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The serum concentration of Dacomitinib can be increased when it is combined with Sildenafil.]
[L01EA05, ponatinib, The serum concentration of Dacomitinib can be increased when it is combined with Ponatinib.]
[B01AF02, apixaban, Dacomitinib may decrease the excretion rate of Apixaban which could result in a higher serum level.]
[C10AX12, lomitapide, The serum concentration of Dacomitinib can be increased when it is combined with Lomitapide.]
[A10BH04, alogliptin, The metabolism of Dacomitinib can be decreased when combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Dacomitinib can be increased when combined with Glycerol phenylbutyrate.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Dacomitinib.]
[G03XC05, ospemifene, The metabolism of Dacomitinib can be decreased when combined with Ospemifene.]
[A10BK02, canagliflozin, The serum concentration of Dacomitinib can be increased when it is combined with Canagliflozin.]
[M04AB03, benzbromarone, The metabolism of Dacomitinib can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The metabolism of Dacomitinib can be decreased when combined with Tegaserod.]
[H03AA04, tiratricol, The therapeutic efficacy of Tiratricol can be decreased when used in combination with Dacomitinib.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Dacomitinib can be decreased when combined with Celecoxib.]
[L04AA18, everolimus, The serum concentration of Everolimus can be increased when it is combined with Dacomitinib.]
[N04AC01, benztropine, The metabolism of Dacomitinib can be decreased when combined with Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Dacomitinib can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Benzyl alcohol.]
[H05AA03, parathyroid hormone, The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Dacomitinib.]
[L01EB03, afatinib, The serum concentration of Afatinib can be increased when it is combined with Dacomitinib.]
[N06AX28, levomilnacipran, The metabolism of Dacomitinib can be decreased when combined with Levomilnacipran.]
[J05AJ03, dolutegravir, Dacomitinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.]
[C08EA02, bepridil, The metabolism of Dacomitinib can be decreased when combined with Bepridil.]
[C02KX05, riociguat, Dacomitinib may decrease the excretion rate of Riociguat which could result in a higher serum level.]
[G03XC02, bazedoxifene, The metabolism of Bazedoxifene can be decreased when combined with Dacomitinib.]
[L01EL01, ibrutinib, The metabolism of Dacomitinib can be decreased when combined with Ibrutinib.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Dacomitinib.]
[N03AF04, eslicarbazepine, The metabolism of Dacomitinib can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The serum concentration of Dacomitinib can be increased when it is combined with Simeprevir.]
[J05AP08, sofosbuvir, Dacomitinib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The metabolism of Dacomitinib can be decreased when combined with Dapagliflozin.]
[C07AB04, acebutolol, The metabolism of Dacomitinib can be decreased when combined with Acebutolol.]
[N05CH03, tasimelteon, The metabolism of Dacomitinib can be decreased when combined with Tasimelteon.]
[A16AA07, metreleptin, The metabolism of Dacomitinib can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Dacomitinib can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Dacomitinib can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Dacomitinib can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The metabolism of Dacomitinib can be decreased when combined with Betaxolol.]
[L04AC11, siltuximab, The metabolism of Dacomitinib can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The serum concentration of Ceritinib can be increased when it is combined with Dacomitinib.]
[B01AC26, vorapaxar, The serum concentration of Dacomitinib can be increased when it is combined with Vorapaxar.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Dacomitinib.]
[L01XH04, belinostat, The metabolism of Belinostat can be decreased when combined with Dacomitinib.]
[L01EM01, idelalisib, The metabolism of Dacomitinib can be decreased when combined with Idelalisib.]
[N07XX08, tafamidis, The serum concentration of Dacomitinib can be increased when it is combined with Tafamidis.]
[R03AC19, olodaterol, The metabolism of Dacomitinib can be decreased when combined with Olodaterol.]
[N05CM19, suvorexant, The serum concentration of Dacomitinib can be increased when it is combined with Suvorexant.]
[A16AX10, eliglustat, The metabolism of Dacomitinib can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Dacomitinib can be increased when combined with Oritavancin.]
[A06AH03, naloxegol, The serum concentration of Naloxegol can be increased when it is combined with Dacomitinib.]
[N04AA02, biperiden, The metabolism of Dacomitinib can be decreased when combined with Biperiden.]
[L04AX05, pirfenidone, The metabolism of Dacomitinib can be decreased when combined with Pirfenidone.]
[L01EX09, nintedanib, The metabolism of Dacomitinib can be decreased when combined with Nintedanib.]
[J05AP09, dasabuvir, The metabolism of Dacomitinib can be decreased when combined with Dasabuvir.]
[L01XK01, olaparib, The metabolism of Dacomitinib can be decreased when combined with Olaparib.]
[B01AA01, dicumarol, The metabolism of Dacomitinib can be decreased when combined with Dicoumarol.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Dacomitinib.]
[N06AX11, mirtazapine, The metabolism of Dacomitinib can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Dacomitinib can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The serum concentration of Dacomitinib can be increased when it is combined with Palbociclib.]
[L01EX08, lenvatinib, Dacomitinib may decrease the excretion rate of Lenvatinib which could result in a higher serum level.]
[L01XH03, panobinostat, The metabolism of Dacomitinib can be decreased when combined with Panobinostat.]
[J05AP07, daclatasvir, The serum concentration of Dacomitinib can be increased when it is combined with Daclatasvir.]
[N02BE01, acetaminophen, The metabolism of Dacomitinib can be increased when combined with Acetaminophen.]
[J05AP06, asunaprevir, The metabolism of Dacomitinib can be decreased when combined with Asunaprevir.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Dacomitinib.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Dacomitinib.]
[A04AD14, rolapitant, The metabolism of Dacomitinib can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, The serum concentration of Dacomitinib can be increased when it is combined with Flibanserin.]
[S01EC01, acetazolamide, The metabolism of Dacomitinib can be decreased when combined with Acetazolamide.]
[A02BC03, lansoprazole, Lansoprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Dacomitinib.]
[J02AC05, isavuconazole, The serum concentration of Dacomitinib can be increased when it is combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be increased when it is combined with Dacomitinib.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Dacomitinib.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Dacomitinib.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Dacomitinib.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Dacomitinib.]
[B01AC27, selexipag, The serum concentration of Selexipag can be increased when it is combined with Dacomitinib.]
[A10BB31, acetohexamide, The metabolism of Dacomitinib can be decreased when combined with Acetohexamide.]
[M04AB05, lesinurad, The metabolism of Dacomitinib can be increased when combined with Lesinurad.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[N05CA05, aprobarbital, The metabolism of Dacomitinib can be increased when combined with Aprobarbital.]
[N03AX23, brivaracetam, The metabolism of Dacomitinib can be decreased when combined with Brivaracetam.]
[L01XX52, venetoclax, The serum concentration of Dacomitinib can be increased when it is combined with Venetoclax.]
[N05AX17, pimavanserin, The metabolism of Dacomitinib can be decreased when combined with Pimavanserin.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Bupivacaine.]
[C07AA19, bupranolol, The metabolism of Dacomitinib can be decreased when combined with Bupranolol.]
[N07BC01, buprenorphine, The metabolism of Dacomitinib can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, The metabolism of Dacomitinib can be decreased when combined with Buspirone.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Dacomitinib.]
[L01XX27, arsenic trioxide, The serum concentration of Dacomitinib can be increased when it is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Dacomitinib can be decreased when combined with Artemether.]
[M02AA03, clofezone, Rabeprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01GX07, azelastine, The metabolism of Dacomitinib can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Dacomitinib can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Dacomitinib can be decreased when combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Dacomitinib can be decreased when combined with Ribociclib.]
[N07XX16, deutetrabenazine, The serum concentration of the active metabolites of Deutetrabenazine can be increased when Deutetrabenazine is used in combination with Dacomitinib.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Oxybuprocaine.]
[D05AX03, calcitriol, The metabolism of Dacomitinib can be increased when combined with Calcitriol.]
[J05AF06, abacavir, The metabolism of Abacavir can be decreased when combined with Dacomitinib.]
[J05AE09, tipranavir, The metabolism of Dacomitinib can be decreased when combined with Tipranavir.]
[H03BA03, benzylthiouracil, The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Dacomitinib.]
[N07XX13, valbenazine, The metabolism of Dacomitinib can be decreased when combined with Valbenazine.]
[L04AB02, infliximab, The metabolism of Dacomitinib can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Dacomitinib can be decreased when combined with Midostaurin.]
[H05AA04, abaloparatide, The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Dacomitinib.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Dacomitinib.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L04AC14, sarilumab, The metabolism of Dacomitinib can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Dacomitinib can be increased when combined with Delafloxacin.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Dacomitinib.]
[D01AC10, bifonazole, The metabolism of Dacomitinib can be decreased when combined with Bifonazole.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Acetylcholine.]
[L01BC06, capecitabine, The metabolism of Dacomitinib can be decreased when combined with Capecitabine.]
[L01XX59, enasidenib, The serum concentration of Dacomitinib can be increased when it is combined with Enasidenib.]
[L01EH02, neratinib, The serum concentration of Dacomitinib can be increased when it is combined with Neratinib.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Dacomitinib.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be increased when it is combined with Dacomitinib.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be increased when it is combined with Dacomitinib.]
[C07AB07, bisoprolol, The serum concentration of Bisoprolol can be increased when it is combined with Dacomitinib.]
[J05AG03, efavirenz, The metabolism of Dacomitinib can be decreased when combined with Efavirenz.]
[C07AA17, bopindolol, The metabolism of Dacomitinib can be decreased when combined with Bopindolol.]
[R03BA02, budesonide, The metabolism of Dacomitinib can be increased when combined with Budesonide.]
[L01EL02, acalabrutinib, The metabolism of Dacomitinib can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, The metabolism of Dacomitinib can be decreased when combined with Letermovir.]
[C01AA02, acetyldigoxins, Dacomitinib may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Capsaicin.]
[A10BK04, ertugliflozin, Dacomitinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.]
[L02BB05, apalutamide, The serum concentration of Dacomitinib can be decreased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Dacomitinib can be increased when combined with Carbamazepine.]
[H03BB01, carbimazole, The therapeutic efficacy of Carbimazole can be decreased when used in combination with Dacomitinib.]
[C07AG02, carvedilol, The serum concentration of Dacomitinib can be increased when it is combined with Carvedilol.]
[B02BX09, fostamatinib, The metabolism of Dacomitinib can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Dacomitinib can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The metabolism of Dacomitinib can be increased when combined with Avatrombopag.]
[L01EC03, encorafenib, The metabolism of Dacomitinib can be decreased when combined with Encorafenib.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Dacomitinib.]
[C07AB08, celiprolol, The metabolism of Dacomitinib can be decreased when combined with Celiprolol.]
[H01CC03, elagolix, The serum concentration of Dacomitinib can be increased when it is combined with Elagolix.]
[L01XX62, ivosidenib, The metabolism of Dacomitinib can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Dacomitinib can be decreased when combined with Tafenoquine.]
[A16AX14, migalastat, The metabolism of Migalastat can be decreased when combined with Dacomitinib.]
[N03AX17, stiripentol, The metabolism of Dacomitinib can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Dacomitinib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[J05AX24, tecovirimat, The metabolism of Dacomitinib can be increased when combined with Tecovirimat.]
[L01EM04, duvelisib, The metabolism of Dacomitinib can be decreased when combined with Duvelisib.]
[S01AA13, fusidic acid, The metabolism of Dacomitinib can be decreased when combined with Fusidic acid.]
[J01AA14, sarecycline, The serum concentration of Dacomitinib can be increased when it is combined with Sarecycline.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Dacomitinib.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Dacomitinib.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Chloroprocaine.]
[M01AC05, lornoxicam, The metabolism of Dacomitinib can be decreased when combined with Lornoxicam.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be increased when it is combined with Dacomitinib.]
[R03BB08, revefenacin, The metabolism of Dacomitinib can be decreased when combined with Revefenacin.]
[L01ED05, lorlatinib, The serum concentration of Dacomitinib can be decreased when it is combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Dacomitinib can be increased when combined with Emapalumab.]
[L01EX12, larotrectinib, The serum concentration of Larotrectinib can be increased when it is combined with Dacomitinib.]
[L01EX13, gilteritinib, The metabolism of Dacomitinib can be decreased when combined with Gilteritinib.]
[L01XJ03, glasdegib, The serum concentration of Dacomitinib can be increased when it is combined with Glasdegib.]
[A06AX05, prucalopride, The serum concentration of Prucalopride can be increased when it is combined with Dacomitinib.]
[B01AC23, cilostazol, The metabolism of Dacomitinib can be decreased when combined with Cilostazol.]
[P02BX04, triclabendazole, The metabolism of Dacomitinib can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Dacomitinib can be increased when combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Dacomitinib.]
[J01FA09, clarithromycin, The metabolism of Dacomitinib can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The serum concentration of Dacomitinib can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, The metabolism of Dacomitinib can be decreased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Dacomitinib can be increased when combined with Cloprednol.]
[C09CA06, candesartan, The metabolism of Dacomitinib can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Dacomitinib can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Dacomitinib can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Dacomitinib.]
[L02BB06, darolutamide, The serum concentration of Dacomitinib can be increased when it is combined with Darolutamide.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Dacomitinib.]
[L01EJ02, fedratinib, The serum concentration of Dacomitinib can be increased when it is combined with Fedratinib.]
[L01EX14, entrectinib, The serum concentration of Dacomitinib can be increased when it is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Pitolisant can be increased when it is combined with Dacomitinib.]
[J04AK08, pretomanid, The metabolism of Dacomitinib can be decreased when combined with Pretomanid.]
[J01XX12, lefamulin, Dacomitinib may decrease the excretion rate of Lefamulin which could result in a higher serum level.]
[N04CX01, istradefylline, The serum concentration of Dacomitinib can be increased when it is combined with Istradefylline.]
[G04BE04, yohimbine, The metabolism of Dacomitinib can be decreased when combined with Yohimbine.]
[J01XX09, daptomycin, The serum concentration of Daptomycin can be increased when it is combined with Dacomitinib.]
[J01DB01, cephalexin, The metabolism of Dacomitinib can be decreased when combined with Cephalexin.]
[J01DB09, cephradine, The metabolism of Dacomitinib can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Dacomitinib can be increased when combined with Deflazacort.]
[N02CC08, lasmiditan, The serum concentration of Dacomitinib can be increased when it is combined with Lasmiditan.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Dacomitinib.]
[G03AC09, desogestrel, The metabolism of Dacomitinib can be decreased when combined with Desogestrel.]
[B06AX03, voxelotor, The serum concentration of Dacomitinib can be increased when it is combined with Voxelotor.]
[N03AX25, cenobamate, The serum concentration of Dacomitinib can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Dacomitinib can be increased when it is combined with Givosiran.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Dacomitinib.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Dacomitinib.]
[R06AB02, dexchlorpheniramine, The metabolism of Dacomitinib can be decreased when combined with Dexchlorpheniramine.]
[L01EX18, avapritinib, The metabolism of Dacomitinib can be decreased when combined with Avapritinib.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Dacomitinib.]
[L01XX72, tazemetostat, The metabolism of Dacomitinib can be decreased when combined with Tazemetostat.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be increased when it is combined with Dacomitinib.]
[M01AX21, diacetylrhein, The metabolism of Dacomitinib can be decreased when combined with Diacerein.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Dacomitinib.]
[J05AB16, remdesivir, The metabolism of Dacomitinib can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Dacomitinib can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Dacomitinib can be decreased when combined with Amprenavir.]
[L04AA38, ozanimod, Dacomitinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, Dacomitinib may decrease the excretion rate of Selumetinib which could result in a higher serum level.]
[N02AA08, dihydrocodeine, The metabolism of Dacomitinib can be decreased when combined with Dihydrocodeine.]
[N02CC06, eletriptan, The metabolism of Dacomitinib can be decreased when combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Dacomitinib can be increased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Dacomitinib can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Dacomitinib can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Dacomitinib can be increased when it is combined with Dronedarone.]
[J01FA13, dirithromycin, The metabolism of Dacomitinib can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Dacomitinib can be decreased when combined with Chloramphenicol.]
[L01FX17, sacituzumab govitecan, The serum concentration of Sacituzumab govitecan can be increased when it is combined with Dacomitinib.]
[L01EH03, tucatinib, Tucatinib may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L01EX17, capmatinib, The serum concentration of Dacomitinib can be increased when it is combined with Capmatinib.]
[D07XB03, fluprednidene, The metabolism of Dacomitinib can be increased when combined with Fluprednidene.]
[G04BD09, trospium, The metabolism of Dacomitinib can be decreased when combined with Trospium.]
[L01EX19, ripretinib, The serum concentration of Dacomitinib can be increased when it is combined with Ripretinib.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Dyclonine.]
[R06AX22, ebastine, The metabolism of Dacomitinib can be decreased when combined with Ebastine.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[P01BB01, proguanil, The metabolism of Dacomitinib can be decreased when combined with Proguanil.]
[L01FX15, belantamab mafodotin, The serum concentration of Belantamab mafodotin can be increased when it is combined with Dacomitinib.]
[L04AC19, satralizumab, The serum concentration of Dacomitinib can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be increased when it is combined with Dacomitinib.]
[P01BA01, chloroquine, The metabolism of Dacomitinib can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be increased when it is combined with Dacomitinib.]
[R06AB04, chlorpheniramine, The metabolism of Dacomitinib can be decreased when combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The metabolism of Dacomitinib can be decreased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, The metabolism of Dacomitinib can be decreased when combined with Chlorpropamide.]
[M03BB03, chlorzoxazone, The metabolism of Dacomitinib can be decreased when combined with Chlorzoxazone.]
[A11CC05, cholecalciferol, The metabolism of Dacomitinib can be decreased when combined with Cholecalciferol.]
[N02BA03, choline salicylate, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Choline salicylate.]
[M01AB08, etodolac, The metabolism of Dacomitinib can be decreased when combined with Etodolac.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Dacomitinib.]
[A16AX20, lonafarnib, The metabolism of Dacomitinib can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Dacomitinib.]
[J05AJ04, cabotegravir, The metabolism of Cabotegravir can be decreased when combined with Dacomitinib.]
[L04AD03, voclosporin, The serum concentration of Dacomitinib can be increased when it is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Dacomitinib can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be increased when it is combined with Dacomitinib.]
[L01EX25, umbralisib, The serum concentration of Dacomitinib can be increased when it is combined with Umbralisib.]
[V03AF12, trilaciclib, Dacomitinib may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[N03AX10, felbamate, The metabolism of Dacomitinib can be increased when combined with Felbamate.]
[R03BA03, flunisolide, The metabolism of Dacomitinib can be increased when combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The metabolism of Dacomitinib can be increased when combined with Fluocinolone acetonide.]
[R03CC15, formoterol, The metabolism of Dacomitinib can be decreased when combined with Formoterol.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be decreased when combined with Dacomitinib.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L03AB10, peginterferon alfa-2b, The metabolism of Dacomitinib can be decreased when combined with Peginterferon alfa-2b.]
[G03GA06, follitropin beta, The therapeutic efficacy of Follitropin can be decreased when used in combination with Dacomitinib.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Dacomitinib.]
[A02BA01, cimetidine, The metabolism of Dacomitinib can be decreased when combined with Cimetidine.]
[N07CA02, cinnarizine, The metabolism of Dacomitinib can be decreased when combined with Cinnarizine.]
[L01XX73, sotorasib, The serum concentration of Dacomitinib can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Dacomitinib can be decreased when combined with Infigratinib.]
[S03AA07, ciprofloxacin, The metabolism of Dacomitinib can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The metabolism of Dacomitinib can be decreased when combined with Citalopram.]
[L04AA48, belumosudil, The serum concentration of Dacomitinib can be increased when it is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Dacomitinib can be decreased when combined with Fexinidazole.]
[L01XX74, belzutifan, The serum concentration of Dacomitinib can be decreased when it is combined with Belzutifan.]
[L01EB10, mobocertinib, The serum concentration of Dacomitinib can be decreased when it is combined with Mobocertinib.]
[L04AA59, avacopan, The metabolism of Dacomitinib can be decreased when combined with Avacopan.]
[R06AA04, clemastine, The metabolism of Dacomitinib can be decreased when combined with Clemastine.]
[M01AG01, mefenamic acid, The metabolism of Dacomitinib can be decreased when combined with Mefenamic acid.]
[A10BB12, glimepiride, The metabolism of Dacomitinib can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Dacomitinib can be decreased when combined with Gliquidone.]
[N06AX25, St. John's wort extract, The serum concentration of Dacomitinib can be decreased when it is combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Dacomitinib can be increased when it is combined with Asciminib.]
[J05AX10, maribavir, The serum concentration of Dacomitinib can be increased when it is combined with Maribavir.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Dacomitinib can be decreased when combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The serum concentration of Dacomitinib can be increased when it is combined with Abrocitinib.]
[J04BA01, clofazimine, The serum concentration of Dacomitinib can be increased when it is combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Dacomitinib can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Dacomitinib can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Dacomitinib can be increased when it is combined with Pacritinib.]
[G03GB02, clomiphene, The serum concentration of Clomifene can be increased when it is combined with Dacomitinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Dacomitinib.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Dacomitinib.]
[C01EB24, mavacamten, The serum concentration of Dacomitinib can be decreased when it is combined with Mavacamten.]
[J02AC06, oteseconazole, The serum concentration of Dacomitinib can be increased when it is combined with Oteseconazole.]
[A04AA01, ondansetron, The metabolism of Dacomitinib can be decreased when combined with Ondansetron.]
[J05AX31, lenacapavir, The metabolism of Dacomitinib can be decreased when combined with Lenacapavir.]
[N05AH02, clozapine, The metabolism of Dacomitinib can be decreased when combined with Clozapine.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be increased when it is combined with Dacomitinib.]
[A10BK06, sotagliflozin, The serum concentration of Dacomitinib can be increased when it is combined with Sotagliflozin.]
[H01AC08, somatrogon, The metabolism of Dacomitinib can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Dacomitinib can be increased when combined with Bimekizumab.]
[R05DA04, codeine, The metabolism of Dacomitinib can be decreased when combined with Codeine.]
[M04AC01, colchicine, The serum concentration of Colchicine can be increased when it is combined with Dacomitinib.]
[L04AA13, leflunomide, The metabolism of Dacomitinib can be decreased when combined with Leflunomide.]
[A10BX03, nateglinide, The metabolism of Dacomitinib can be decreased when combined with Nateglinide.]
[J01FA15, telithromycin, The metabolism of Dacomitinib can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Dacomitinib can be decreased when combined with Ciclesonide.]
[M01AH03, valdecoxib, The metabolism of Dacomitinib can be decreased when combined with Valdecoxib.]
[N02CC05, almotriptan, The metabolism of Dacomitinib can be decreased when combined with Almotriptan.]
[M01AH04, parecoxib, The metabolism of Dacomitinib can be decreased when combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Dacomitinib can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Acyclovir.]
[N05BA10, ketazolam, The metabolism of Dacomitinib can be decreased when combined with Ketazolam.]
[L02BA03, fulvestrant, The metabolism of Fulvestrant can be decreased when combined with Dacomitinib.]
[L01EA01, imatinib, The serum concentration of Dacomitinib can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Dacomitinib can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, Esomeprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dacomitinib.]
[N03AX09, lamotrigine, The metabolism of Lamotrigine can be decreased when combined with Dacomitinib.]
[S01BA03, cortisone, The metabolism of Dacomitinib can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The metabolism of Dacomitinib can be decreased when combined with Lofexidine.]
[C08CA11, manidipine, The metabolism of Dacomitinib can be decreased when combined with Manidipine.]
[C07AA14, mepindolol, The metabolism of Dacomitinib can be decreased when combined with Mepindolol.]
[H02AB15, meprednisone, The metabolism of Dacomitinib can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Dacomitinib can be decreased when combined with Mequitazine.]
[R06AE03, cyclizine, The metabolism of Dacomitinib can be decreased when combined with Cyclizine.]
[N05AD03, metylperon, The metabolism of Dacomitinib can be decreased when combined with Melperone.]
[J01FA03, midecamycin, The metabolism of Dacomitinib can be decreased when combined with Midecamycin.]
[J05AF07, tenofovir disoproxil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Dacomitinib.]
[L01AA01, cyclophosphamide, The metabolism of Dacomitinib can be increased when combined with Cyclophosphamide.]
[N06AX07, minaprine, The metabolism of Dacomitinib can be decreased when combined with Minaprine.]
[S01XA18, cyclosporine, The metabolism of Dacomitinib can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The metabolism of Dacomitinib can be decreased when combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Dacomitinib can be increased when combined with Modafinil.]
[C10AA07, rosuvastatin, The metabolism of Dacomitinib can be decreased when combined with Rosuvastatin.]
[C03XA02, conivaptan, The metabolism of Dacomitinib can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Cytarabine.]
[G04BE09, vardenafil, The serum concentration of Dacomitinib can be increased when it is combined with Vardenafil.]
[M01AH05, etoricoxib, The metabolism of Dacomitinib can be decreased when combined with Etoricoxib.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be increased when it is combined with Dacomitinib.]
[G03XA01, danazol, The metabolism of Dacomitinib can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Dacomitinib can be increased when combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Dacomitinib can be decreased when combined with Daunorubicin.]
[C02CC04, debrisoquin, The metabolism of Dacomitinib can be decreased when combined with Debrisoquine.]
[A04AD11, nabilone, The metabolism of Dacomitinib can be decreased when combined with Nabilone.]
[M01AX01, nabumetone, The metabolism of Dacomitinib can be decreased when combined with Nabumetone.]
[C07AB12, nebivolol, The metabolism of Dacomitinib can be decreased when combined with Nebivolol.]
[N06AX06, nefazodone, The metabolism of Dacomitinib can be decreased when combined with Nefazodone.]
[L02BB02, nilutamide, The metabolism of Dacomitinib can be decreased when combined with Nilutamide.]
[N03AG06, tiagabine, The metabolism of Tiagabine can be decreased when combined with Dacomitinib.]
[N06AB10, escitalopram, The serum concentration of Dacomitinib can be increased when it is combined with Escitalopram.]
[G04BD08, solifenacin, The metabolism of Dacomitinib can be decreased when combined with Solifenacin.]
[N06AA01, desipramine, The metabolism of Dacomitinib can be decreased when combined with Desipramine.]
[L01XA03, oxaliplatin, Dacomitinib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The metabolism of Dacomitinib can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Dacomitinib can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Dacomitinib can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dacomitinib can be decreased when combined with Dexfenfluramine.]
[L04AB04, adalimumab, The metabolism of Dacomitinib can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Dacomitinib can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, The metabolism of Dacomitinib can be decreased when combined with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Dacomitinib can be decreased when combined with Dextromethorphan.]
[N03AC01, paramethadione, The metabolism of Dacomitinib can be decreased when combined with Paramethadione.]
[H05AA02, teriparatide, The therapeutic efficacy of Teriparatide can be decreased when used in combination with Dacomitinib.]
[N06AB05, paroxetine, The metabolism of Dacomitinib can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Dacomitinib can be decreased when combined with Clopidogrel.]
[N05BA01, diazepam, The metabolism of Dacomitinib can be decreased when combined with Diazepam.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Cinchocaine.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Dacomitinib.]
[J01CF01, dicloxacillin, The metabolism of Dacomitinib can be increased when combined with Dicloxacillin.]
[L01DC04, ixabepilone, The serum concentration of Dacomitinib can be increased when it is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Dacomitinib can be decreased when combined with Erlotinib.]
[L02AA01, diethylstilbestrol, The metabolism of Dacomitinib can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Dacomitinib can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Dacomitinib can be increased when combined with Difluocortolone.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Dacomitinib.]
[C01AA05, digoxin, Dacomitinib may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C10AX09, ezetimibe, Dacomitinib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[C04AE04, dihydroergocristine, The metabolism of Dacomitinib can be decreased when combined with Dihydroergocristine.]
[N02CA01, dihydroergotamine, The metabolism of Dacomitinib can be decreased when combined with Dihydroergotamine.]
[N02AA03, hydromorphone, The metabolism of Dacomitinib can be decreased when combined with Hydromorphone.]
[J05AE08, atazanavir, The metabolism of Dacomitinib can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Dacomitinib can be decreased when combined with Treprostinil.]
[H03BC01, potassium perchlorate, The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Dacomitinib.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Dacomitinib can be decreased when combined with Diltiazem.]
[M02AX03, dimethyl sulfoxide, The metabolism of Dacomitinib can be decreased when combined with Dimethyl sulfoxide.]
[C05CA03, diosmin, The serum concentration of Dacomitinib can be increased when it is combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Dacomitinib can be decreased when combined with Quazepam.]
[A03FA02, cisapride, The metabolism of Dacomitinib can be decreased when combined with Cisapride.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be increased when it is combined with Dacomitinib.]
[N05AL04, remoxipride, The metabolism of Dacomitinib can be decreased when combined with Remoxipride.]
[S02AA12, rifamycin SV, The serum concentration of Dacomitinib can be increased when it is combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Dacomitinib can be increased when combined with Rifapentine.]
[D06AX11, rifaximin, The serum concentration of Rifaximin can be increased when it is combined with Dacomitinib.]
[N07XX02, riluzole, Dacomitinib may decrease the excretion rate of Riluzole which could result in a higher serum level.]
[N05AX08, risperidone, The metabolism of Dacomitinib can be decreased when combined with Risperidone.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Ropivacaine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Dacomitinib.]
[A04AD12, aprepitant, The metabolism of Dacomitinib can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be increased when it is combined with Dacomitinib.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Dacomitinib.]
[J05AE07, fosamprenavir, The metabolism of Dacomitinib can be decreased when combined with Fosamprenavir.]
[S01BC05, ketorolac, The metabolism of Dacomitinib can be decreased when combined with Ketorolac.]
[C02KX02, ambrisentan, The serum concentration of Ambrisentan can be increased when it is combined with Dacomitinib.]
[C01EB18, ranolazine, The serum concentration of Ranolazine can be increased when it is combined with Dacomitinib.]
[R03AC12, salmeterol, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Salmeterol.]
[H05BA01, salmon calcitonin, The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dacomitinib.]
[A03FA03, domperidone, The metabolism of Dacomitinib can be decreased when combined with Domperidone.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Dopamine.]
[N06AA16, dothiepin, The metabolism of Dacomitinib can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Dacomitinib can be decreased when combined with Doxepin.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be increased when it is combined with Dacomitinib.]
[N06AB06, sertraline, The metabolism of Dacomitinib can be decreased when combined with Sertraline.]
[C10AA01, simvastatin, The serum concentration of Dacomitinib can be increased when it is combined with Simvastatin.]
[N02CC01, sumatriptan, Dacomitinib may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[C07AB13, talinolol, The metabolism of Dacomitinib can be decreased when combined with Talinolol.]
[H01AA01, corticotropin, The metabolism of Dacomitinib can be increased when combined with Corticotropin.]
[M01AC02, tenoxicam, The metabolism of Dacomitinib can be decreased when combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Dacomitinib can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Dacomitinib can be decreased when combined with Tertatolol.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Dacomitinib.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Dacomitinib.]
[N03AX11, topiramate, The metabolism of Dacomitinib can be increased when combined with Topiramate.]
[L02BA02, toremifene, The serum concentration of Dacomitinib can be increased when it is combined with Toremifene.]
[C03CA04, torsemide, The metabolism of Dacomitinib can be decreased when combined with Torasemide.]
[G03GA05, follitropin alfa, The therapeutic efficacy of Follitropin can be decreased when used in combination with Dacomitinib.]
[L01CA04, vinorelbine, The metabolism of Dacomitinib can be decreased when combined with Vinorelbine.]
[S01GX10, epinastine, The metabolism of Dacomitinib can be decreased when combined with Epinastine.]
[N06AX16, venlafaxine, The metabolism of Dacomitinib can be decreased when combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Dacomitinib can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Dacomitinib can be decreased when combined with Epinephrine.]
[N05CF02, zolpidem, The metabolism of Dacomitinib can be decreased when combined with Zolpidem.]
[N03AX15, zonisamide, The serum concentration of Dacomitinib can be increased when it is combined with Zonisamide.]
[N05CF01, zopiclone, The metabolism of Dacomitinib can be decreased when combined with Zopiclone.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Guanfacine.]
[N02CA02, ergotamine, The metabolism of Dacomitinib can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The serum concentration of Dacomitinib can be increased when it is combined with Erythromycin.]
[A02BC02, pantoprazole, Pantoprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H05BX01, cinacalcet, The metabolism of Dacomitinib can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Dacomitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[J04AK02, ethambutol, The metabolism of Dacomitinib can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Dacomitinib can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Dacomitinib can be increased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Dacomitinib can be decreased when combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Dacomitinib.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Meloxicam.]
[S01XA06, ethylmorphine, The metabolism of Dacomitinib can be decreased when combined with Ethylmorphine.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Etidocaine.]
[L01CB01, etoposide, The serum concentration of Etoposide can be increased when it is combined with Dacomitinib.]
[N05AE03, sertindole, The metabolism of Dacomitinib can be decreased when combined with Sertindole.]
[L04AD02, tacrolimus, The serum concentration of Dacomitinib can be increased when it is combined with Tacrolimus.]
[R06AX11, astemizole, The metabolism of Dacomitinib can be decreased when combined with Astemizole.]
[R06AX12, terfenadine, The metabolism of Dacomitinib can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Dacomitinib can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The metabolism of Dacomitinib can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Dacomitinib can be decreased when combined with Encainide.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Dacomitinib can be decreased when combined with Albendazole.]
[C08CA02, felodipine, The metabolism of Dacomitinib can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The metabolism of Dacomitinib can be decreased when combined with Fenfluramine.]
[L01BB06, clofarabine, Dacomitinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA40, cladribine, Dacomitinib may decrease the excretion rate of Cladribine which could result in a higher serum level.]
[N07AX03, cevimeline, The metabolism of Dacomitinib can be decreased when combined with Cevimeline.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Dacomitinib.]
[J01CF05, floxacillin, The metabolism of Dacomitinib can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The serum concentration of Dacomitinib can be increased when it is combined with Fluconazole.]
[N07CA03, flunarizine, The metabolism of Dacomitinib can be decreased when combined with Flunarizine.]
[N05CD03, flunitrazepam, The metabolism of Dacomitinib can be decreased when combined with Flunitrazepam.]
[D07AC08, fluocinonide, The metabolism of Dacomitinib can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Dacomitinib can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Dacomitinib can be increased when combined with Ethanol.]
[L01BC09, floxuridine, The metabolism of Dacomitinib can be decreased when combined with Floxuridine.]
[L01BC02, fluorouracil, The metabolism of Dacomitinib can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The serum concentration of Dacomitinib can be increased when it is combined with Fluoxetine.]
[N05AB02, fluphenazine, The metabolism of Dacomitinib can be decreased when combined with Fluphenazine.]
[S01BC04, flurbiprofen, The metabolism of Flurbiprofen can be decreased when combined with Dacomitinib.]
[V04CX02, folic acid, Dacomitinib may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[J05AE10, darunavir, The serum concentration of Dacomitinib can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, The metabolism of Furosemide can be decreased when combined with Dacomitinib.]
[N06DA04, galantamine, The metabolism of Dacomitinib can be decreased when combined with Galantamine.]
[S01AD09, ganciclovir, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Ganciclovir.]
[N03AA04, barbexaclone, The metabolism of Dacomitinib can be increased when combined with Barbexaclone.]
[C10AB04, gemfibrozil, The metabolism of Dacomitinib can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be increased when it is combined with Dacomitinib.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be increased when it is combined with Dacomitinib.]
[J05AG04, etravirine, The metabolism of Dacomitinib can be increased when combined with Etravirine.]
[L01EH01, lapatinib, The serum concentration of Dacomitinib can be increased when it is combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Dacomitinib can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Dacomitinib can be decreased when combined with Gliclazide.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Dacomitinib.]
[N05CM18, dexmedetomidine, The metabolism of Dacomitinib can be decreased when combined with Dexmedetomidine.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Dacomitinib.]
[C02CA04, doxazosin, The metabolism of Dacomitinib can be decreased when combined with Doxazosin.]
[H01AB01, thyrotropin alfa, The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dacomitinib.]
[L01EX02, sorafenib, The serum concentration of Dacomitinib can be increased when it is combined with Sorafenib.]
[C07AB09, esmolol, The metabolism of Dacomitinib can be decreased when combined with Esmolol.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Dacomitinib.]
[D01BA01, griseofulvin, The metabolism of Dacomitinib can be increased when combined with Griseofulvin.]
[P01BX01, halofantrine, The metabolism of Dacomitinib can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Dacomitinib.]
[N01AB01, halothane, The metabolism of Dacomitinib can be decreased when combined with Halothane.]
[N05AH04, quetiapine, The metabolism of Dacomitinib can be decreased when combined with Quetiapine.]
[L01CE02, irinotecan, The risk or severity of neutropenia can be increased when Dacomitinib is combined with Irinotecan.]
[M04AA01, allopurinol, Dacomitinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C09CA01, losartan, The metabolism of Dacomitinib can be decreased when combined with Losartan.]
[G03DC01, allylestrenol, The metabolism of Dacomitinib can be decreased when combined with Allylestrenol.]
[N05CA16, hexobarbital, The metabolism of Dacomitinib can be decreased when combined with Hexobarbital.]
[J05AG01, nevirapine, The metabolism of Dacomitinib can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Dacomitinib can be decreased when combined with Nilvadipine.]
[C02DB02, hydralazine, The metabolism of Dacomitinib can be decreased when combined with Hydralazine.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Dacomitinib.]
[S02BA01, hydrocortisone, The metabolism of Dacomitinib can be increased when combined with Hydrocortisone.]
[P01BA02, hydroxychloroquine, The metabolism of Dacomitinib can be decreased when combined with Hydroxychloroquine.]
[N05BB01, hydroxyzine, The metabolism of Dacomitinib can be decreased when combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Dacomitinib can be increased when combined with Rifabutin.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Dacomitinib.]
[L01DB06, idarubicin, The metabolism of Dacomitinib can be decreased when combined with Idarubicin.]
[L01AA06, ifosfamide, The metabolism of Dacomitinib can be increased when combined with Ifosfamide.]
[N06AA02, imipramine, The metabolism of Dacomitinib can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Dacomitinib can be increased when combined with Paclitaxel.]
[L01CE01, topotecan, The serum concentration of Topotecan can be increased when it is combined with Dacomitinib.]
[S01BC01, indomethacin, The metabolism of Indomethacin can be decreased when combined with Dacomitinib.]
[N06AX17, milnacipran, The metabolism of Dacomitinib can be decreased when combined with Milnacipran.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Articaine.]
[A10BH01, sitagliptin, The serum concentration of Sitagliptin can be increased when it is combined with Dacomitinib.]
[N05CH02, ramelteon, The metabolism of Dacomitinib can be decreased when combined with Ramelteon.]
[C10AA06, cerivastatin, The metabolism of Dacomitinib can be increased when combined with Cerivastatin.]
[C07AA01, alprenolol, The metabolism of Dacomitinib can be decreased when combined with Alprenolol.]
[V03AB01, ipecac, The metabolism of Dacomitinib can be decreased when combined with Ipecac.]
[N06AF05, iproniazid, The metabolism of Dacomitinib can be decreased when combined with Iproniazid.]
[P01AX06, atovaquone, The metabolism of Dacomitinib can be decreased when combined with Atovaquone.]
[N04BX02, entacapone, The metabolism of Dacomitinib can be decreased when combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Dacomitinib can be decreased when combined with Isoniazid.]
[P02CF01, ivermectin, Dacomitinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[N06AX18, reboxetine, The metabolism of Dacomitinib can be decreased when combined with Reboxetine.]
[L04AC07, tocilizumab, The metabolism of Dacomitinib can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Dacomitinib can be decreased when combined with Ketamine.]
[B01AC22, prasugrel, The metabolism of Dacomitinib can be decreased when combined with Prasugrel.]
[J02AB02, ketoconazole, The metabolism of Dacomitinib can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Dacomitinib can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, The metabolism of Dacomitinib can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, The metabolism of Ketoprofen can be decreased when combined with Dacomitinib.]
[V03AC03, deferasirox, The metabolism of Dacomitinib can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Dacomitinib can be increased when combined with Abatacept.]
[N04BC09, rotigotine, The metabolism of Dacomitinib can be decreased when combined with Rotigotine.]
[C07AG01, labetalol, The metabolism of Dacomitinib can be decreased when combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Amantadine.]
[N03AX18, lacosamide, The metabolism of Dacomitinib can be decreased when combined with Lacosamide.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Lidocaine.]
[N06BA13, armodafinil, The metabolism of Dacomitinib can be increased when combined with Armodafinil.]
[N02CA07, lisuride, The metabolism of Dacomitinib can be decreased when combined with Lisuride.]
[A07DA03, loperamide, The excretion of Loperamide can be decreased when combined with Dacomitinib.]
[C10AA02, lovastatin, The metabolism of Dacomitinib can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The serum concentration of Dacomitinib can be increased when it is combined with Loxapine.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Dacomitinib.]
[L01EG01, temsirolimus, The serum concentration of Dacomitinib can be increased when it is combined with Temsirolimus.]
[L01BA05, pralatrexate, Dacomitinib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Dacomitinib can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The serum concentration of Mannitol can be increased when it is combined with Dacomitinib.]
[N06AA21, maprotiline, The metabolism of Dacomitinib can be decreased when combined with Maprotiline.]
[R06AE05, meclizine, The metabolism of Dacomitinib can be decreased when combined with Meclizine.]
[C01AA08, medigoxin, Dacomitinib may decrease the excretion rate of Metildigoxin which could result in a higher serum level.]
[P01BC02, mefloquine, The serum concentration of Dacomitinib can be increased when it is combined with Mefloquine.]
[N02AB02, meperidine, The metabolism of Dacomitinib can be decreased when combined with Meperidine.]
[N03AB04, mephenytoin, The metabolism of Dacomitinib can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, The metabolism of Dacomitinib can be increased when combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Mepivacaine.]
[L02BG01, aminoglutethimide, The metabolism of Dacomitinib can be increased when combined with Aminoglutethimide.]
[N05AC03, mesoridazine, The metabolism of Dacomitinib can be decreased when combined with Mesoridazine.]
[N05AX13, paliperidone, The serum concentration of Dacomitinib can be increased when it is combined with Paliperidone.]
[A04AA04, dolasetron, The metabolism of Dacomitinib can be decreased when combined with Dolasetron.]
[H01CB03, lanreotide, The metabolism of Dacomitinib can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Dacomitinib can be decreased when combined with Methadone.]
[N06BA03, methamphetamine, The metabolism of Dacomitinib can be decreased when combined with Metamfetamine.]
[J05AF05, lamivudine, Dacomitinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[H03BB02, methimazole, The metabolism of Dacomitinib can be decreased when combined with Methimazole.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Dacomitinib.]
[N05AA02, methotrimeprazine, The metabolism of Dacomitinib can be decreased when combined with Methotrimeprazine.]
[N02BG09, methoxyflurane, The metabolism of Dacomitinib can be decreased when combined with Methoxyflurane.]
[V04CG05, methylene blue, The serum concentration of Dacomitinib can be increased when it is combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Dacomitinib can be decreased when combined with Methylergometrine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Dacomitinib.]
[H02AB04, methylprednisolone, The metabolism of Dacomitinib can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The metabolism of Dacomitinib can be increased when combined with Rufinamide.]
[N02CA04, methysergide, The metabolism of Dacomitinib can be decreased when combined with Methysergide.]
[A03FA01, metoclopramide, The metabolism of Dacomitinib can be decreased when combined with Metoclopramide.]
[C07AB02, metoprolol, The metabolism of Dacomitinib can be decreased when combined with Metoprolol.]
[P01AB01, metronidazole, The metabolism of Dacomitinib can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Dacomitinib can be increased when combined with Metyrapone.]
[C01BB02, mexiletine, The metabolism of Dacomitinib can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The metabolism of Dacomitinib can be decreased when combined with Mianserin.]
[S02AA13, miconazole, The metabolism of Dacomitinib can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Dacomitinib can be decreased when combined with Aminophenazone.]
[N05CD08, midazolam, The metabolism of Dacomitinib can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The serum concentration of Dacomitinib can be decreased when it is combined with Mifepristone.]
[C09CA03, valsartan, The metabolism of Dacomitinib can be decreased when combined with Valsartan.]
[D11AX01, minoxidil, The metabolism of Minoxidil can be decreased when combined with Dacomitinib.]
[J01FA11, miocamycin, The metabolism of Dacomitinib can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Dacomitinib can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, Dacomitinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.]
[N06BA12, lisdexamfetamine, The metabolism of Dacomitinib can be decreased when combined with Lisdexamfetamine.]
[L03AC01, aldesleukin, The metabolism of Dacomitinib can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Dacomitinib can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Dacomitinib.]
[N02AA01, morphine, The serum concentration of Morphine can be increased when it is combined with Dacomitinib.]
[A04AA05, palonosetron, The metabolism of Dacomitinib can be decreased when combined with Palonosetron.]
[L04AB05, certolizumab pegol, The metabolism of Dacomitinib can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Dacomitinib.]
[L04AA06, mycophenolic acid, The metabolism of Mycophenolic acid can be decreased when combined with Dacomitinib.]
[N05CA02, amobarbital, The metabolism of Dacomitinib can be increased when combined with Amobarbital.]
[J05AJ01, raltegravir, The metabolism of Raltegravir can be decreased when combined with Dacomitinib.]
[P01BA06, amodiaquine, The metabolism of Dacomitinib can be decreased when combined with Amodiaquine.]
[G04CA04, silodosin, The excretion of Silodosin can be decreased when combined with Dacomitinib.]
[G03XC01, raloxifene, The metabolism of Dacomitinib can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Dacomitinib.]
[N03AB05, fosphenytoin, The metabolism of Dacomitinib can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, The metabolism of Dacomitinib can be decreased when combined with Nadolol.]
[J01CF06, nafcillin, The metabolism of Dacomitinib can be increased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Dacomitinib can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The metabolism of Naltrexone can be decreased when combined with Dacomitinib.]
[L04AC03, anakinra, The metabolism of Dacomitinib can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Dacomitinib can be decreased when combined with Amphetamine.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Dacomitinib.]
[A10BG01, troglitazone, The metabolism of Dacomitinib can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Dacomitinib can be decreased when combined with Duloxetine.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Dacomitinib.]
[L01CD02, docetaxel, The metabolism of Dacomitinib can be decreased when combined with Docetaxel.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Dacomitinib.]
[N06AX23, desvenlafaxine, The metabolism of Dacomitinib can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Dacomitinib can be decreased when combined with Febuxostat.]
[C10AD02, niacin, The metabolism of Dacomitinib can be decreased when combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Dacomitinib can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The metabolism of Dacomitinib can be decreased when combined with Nicergoline.]
[P02DA01, niclosamide, The metabolism of Dacomitinib can be decreased when combined with Niclosamide.]
[C08CA05, nifedipine, The metabolism of Dacomitinib can be decreased when combined with Nifedipine.]
[J01XE01, nitrofurantoin, Dacomitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Pramipexole.]
[C01CA03, norepinephrine, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Norepinephrine.]
[G03DC02, norethindrone, The metabolism of Dacomitinib can be decreased when combined with Norethisterone.]
[C02KX01, bosentan, The metabolism of Dacomitinib can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be increased when it is combined with Dacomitinib.]
[R05DA07, noscapine, The metabolism of Dacomitinib can be decreased when combined with Noscapine.]
[A16AX07, sapropterin, The serum concentration of Dacomitinib can be increased when it is combined with Sapropterin.]
[H01CB02, octreotide, The serum concentration of Dacomitinib can be increased when it is combined with Octreotide.]
[J01FA05, oleandomycin, The metabolism of Dacomitinib can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Dacomitinib can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, Omeprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02AA02, opium, The metabolism of Dacomitinib can be decreased when combined with Opium.]
[G04CA02, tamsulosin, The metabolism of Dacomitinib can be decreased when combined with Tamsulosin.]
[P02BA02, oxamniquine, The metabolism of Dacomitinib can be decreased when combined with Oxamniquine.]
[A14AA08, oxandrolone, The metabolism of Dacomitinib can be decreased when combined with Oxandrolone.]
[C07AA02, oxprenolol, The metabolism of Dacomitinib can be decreased when combined with Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Dacomitinib can be decreased when combined with Oxycodone.]
[N02AA11, oxymorphone, The metabolism of Dacomitinib can be decreased when combined with Oxymorphone.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Pancuronium.]
[H02AB05, paramethasone, The metabolism of Dacomitinib can be increased when combined with Paramethasone.]
[G04BD11, fesoterodine, The metabolism of Dacomitinib can be decreased when combined with Fesoterodine.]
[C07AA23, penbutolol, The metabolism of Dacomitinib can be decreased when combined with Penbutolol.]
[N05CA01, pentobarbital, The metabolism of Dacomitinib can be increased when combined with Pentobarbital.]
[C08EX02, perhexiline, The metabolism of Dacomitinib can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The metabolism of Dacomitinib can be decreased when combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Dacomitinib can be decreased when combined with Phenacetin.]
[A10BA01, phenformin, The metabolism of Dacomitinib can be decreased when combined with Phenformin.]
[N03AA02, phenobarbital, The metabolism of Dacomitinib can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Dacomitinib.]
[M02AA01, phenylbutazone, The metabolism of Dacomitinib can be increased when combined with Phenylbutazone.]
[A02BC06, dexlansoprazole, Dexlansoprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N03AB02, phenytoin, The metabolism of Dacomitinib can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Dacomitinib can be increased when combined with Golimumab.]
[L02BB03, bicalutamide, The metabolism of Dacomitinib can be decreased when combined with Bicalutamide.]
[C08CX01, mibefradil, The serum concentration of Dacomitinib can be increased when it is combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Dacomitinib.]
[C07AA03, pindolol, The metabolism of Dacomitinib can be decreased when combined with Pindolol.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Dacomitinib.]
[J05AE01, saquinavir, The metabolism of Dacomitinib can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Dacomitinib can be decreased when combined with Piperazine.]
[N05AC04, pipothiazine, The metabolism of Dacomitinib can be decreased when combined with Pipotiazine.]
[S01BC06, piroxicam, The metabolism of Dacomitinib can be decreased when combined with Piroxicam.]
[J05AG02, delavirdine, The metabolism of Dacomitinib can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Dacomitinib can be decreased when combined with Irbesartan.]
[A10BG02, rosiglitazone, The metabolism of Dacomitinib can be decreased when combined with Rosiglitazone.]
[A03AE01, alosetron, The metabolism of Dacomitinib can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Dacomitinib can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The serum concentration of Dacomitinib can be increased when it is combined with Ritonavir.]
[V03AB21, potassium iodide, The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Dacomitinib.]
[C10AA08, pitavastatin, Dacomitinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[C07AB01, practolol, The metabolism of Dacomitinib can be decreased when combined with Practolol.]
[C02CA01, prazosin, Dacomitinib may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[S03BA02, prednisolone, The metabolism of Dacomitinib can be increased when combined with Prednisolone.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Dacomitinib can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Dacomitinib can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Dacomitinib can be increased when combined with Probenecid.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Dacomitinib.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Procaine.]
[C10AB05, fenofibrate, The metabolism of Dacomitinib can be decreased when combined with Fenofibrate.]
[N05AB04, prochlorperazine, The metabolism of Dacomitinib can be decreased when combined with Prochlorperazine.]
[G03DA04, progesterone, The metabolism of Dacomitinib can be decreased when combined with Progesterone.]
[N05AA03, promazine, The metabolism of Dacomitinib can be decreased when combined with Promazine.]
[R06AD02, promethazine, The metabolism of Dacomitinib can be decreased when combined with Promethazine.]
[C01BC03, propafenone, The serum concentration of Dacomitinib can be increased when it is combined with Propafenone.]
[R06AX26, fexofenadine, The serum concentration of Fexofenadine can be increased when it is combined with Dacomitinib.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be increased when it is combined with Dacomitinib.]
[N01AX10, propofol, The metabolism of Dacomitinib can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Dacomitinib can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, The metabolism of Dacomitinib can be decreased when combined with Propranolol.]
[H03BA02, propylthiouracil, The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Dacomitinib.]
[R03DC03, montelukast, The metabolism of Dacomitinib can be decreased when combined with Montelukast.]
[N05AX12, aripiprazole, The metabolism of Dacomitinib can be decreased when combined with Aripiprazole.]
[R06AC01, pyrilamine, The metabolism of Dacomitinib can be decreased when combined with Mepyramine.]
[C01BA01, quinidine, The serum concentration of Dacomitinib can be increased when it is combined with Quinidine.]
[P01BC01, quinine, The metabolism of Dacomitinib can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Dacomitinib can be decreased when combined with Ranitidine.]
[C02AA02, reserpine, The serum concentration of Dacomitinib can be increased when it is combined with Reserpine.]
[J04AB02, rifampin, The serum concentration of Dacomitinib can be decreased when it is combined with Rifampicin.]
[J01FA06, roxithromycin, The metabolism of Dacomitinib can be decreased when combined with Roxithromycin.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[S01BC08, salicylic acid, The metabolism of Dacomitinib can be decreased when combined with Salicylic acid.]
[N05CA06, secobarbital, The metabolism of Dacomitinib can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Dacomitinib can be decreased when combined with Selegiline.]
[H01CB01, somatostatin, The metabolism of Dacomitinib can be decreased when combined with Somatostatin.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Dacomitinib.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be increased when it is combined with Dacomitinib.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be increased when it is combined with Dacomitinib.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Dacomitinib.]
[N03AG01, valproic acid, The metabolism of Dacomitinib can be decreased when combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Dacomitinib can be increased when combined with Hydrocortisone butyrate.]
